{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T02:29:03Z","timestamp":1794796143349,"version":"4.9.1"},"reference-count":377,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T00:00:00Z","timestamp":1716768000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioactive Materials"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.bioactmat.2024.05.042","type":"journal-article","created":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T12:05:37Z","timestamp":1719921937000},"page":"427-454","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Biochemical hallmarks-targeting antineoplastic nanotherapeutics"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-2989-8085","authenticated-orcid":false,"given":"Jing","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6102-8204","authenticated-orcid":false,"given":"He","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5895-6628","authenticated-orcid":false,"given":"Tianyi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9516-2349","authenticated-orcid":false,"given":"Qi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6025-7476","authenticated-orcid":false,"given":"Yun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9289-9559","authenticated-orcid":false,"given":"Yu","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4763-1363","authenticated-orcid":false,"given":"Haoran","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8077-6874","authenticated-orcid":false,"given":"Shandeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8876-6665","authenticated-orcid":false,"given":"Ke","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1711-2692","authenticated-orcid":false,"given":"Jing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5232-8863","authenticated-orcid":false,"given":"Jianxun","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9859","key":"10.1016\/j.bioactmat.2024.05.042_bib1","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lozano","year":"2012","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.bioactmat.2024.05.042_bib2","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.tips.2014.09.008","article-title":"Prodrug-based nanoparticulate drug delivery strategies for cancer therapy","volume":"35","author":"Luo","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.bioactmat.2024.05.042_bib3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrc.2016.108","article-title":"Cancer nanomedicine: Progress, challenges and opportunities","volume":"17","author":"Shi","year":"2017","journal-title":"Nat. Rev. Cancer"},{"issue":"8","key":"10.1016\/j.bioactmat.2024.05.042_bib4","doi-asserted-by":"crossref","first-page":"12567","DOI":"10.1021\/acsnano.1c02103","article-title":"Nanotechnology for boosting cancer immunotherapy and remodeling tumor microenvironment: The horizons in cancer treatment","volume":"15","author":"Gao","year":"2021","journal-title":"ACS Nano"},{"issue":"6","key":"10.1016\/j.bioactmat.2024.05.042_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202107434","article-title":"Polyprodrug nanomedicines: An emerging paradigm for cancer therapy","volume":"34","author":"Yang","year":"2022","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.bioactmat.2024.05.042_bib6","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.cclet.2021.07.025","article-title":"An in situ nanoparticle recombinant strategy for the enhancement of photothermal therapy","volume":"33","author":"Liu","year":"2022","journal-title":"Chin. Chem. Lett."},{"issue":"7","key":"10.1016\/j.bioactmat.2024.05.042_bib7","doi-asserted-by":"crossref","first-page":"590","DOI":"10.3109\/1061186X.2016.1154561","article-title":"A review of the ligands and related targeting strategies for active targeting of paclitaxel to tumours","volume":"24","author":"Li","year":"2016","journal-title":"J. Drug Target."},{"key":"10.1016\/j.bioactmat.2024.05.042_bib8","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jconrel.2016.04.028","article-title":"Meta-analysis of clinical and preclinical studies comparing the anticancer efficacy of liposomal versus conventional non-liposomal doxorubicin","volume":"232","author":"Petersen","year":"2016","journal-title":"J. Control. Release"},{"issue":"11","key":"10.1016\/j.bioactmat.2024.05.042_bib9","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1038\/s41563-021-01047-7","article-title":"Obstacles and opportunities in a forward vision for cancer nanomedicine","volume":"20","author":"de Lazaro","year":"2021","journal-title":"Nat. Mater."},{"issue":"4","key":"10.1016\/j.bioactmat.2024.05.042_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20040840","article-title":"Targeting tumor microenvironment for cancer therapy","volume":"20","author":"Roma-Rodrigues","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.bioactmat.2024.05.042_bib11","doi-asserted-by":"crossref","first-page":"761","DOI":"10.7150\/jca.17648","article-title":"Role of tumor microenvironment in tumorigenesis","volume":"8","author":"Wang","year":"2017","journal-title":"J. Cancer"},{"key":"10.1016\/j.bioactmat.2024.05.042_bib12","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3389\/fmed.2018.00085","article-title":"Overview on clinical relevance of intra-tumor heterogeneity","volume":"5","author":"Stanta","year":"2018","journal-title":"Front. Med."},{"issue":"2","key":"10.1016\/j.bioactmat.2024.05.042_bib13","doi-asserted-by":"crossref","first-page":"100023","DOI":"10.1016\/j.mbm.2023.100023","article-title":"Extracellular cell matrix stiffness-driven drug resistance of breast cancer cells via EGFR activation","volume":"1","author":"Li","year":"2023","journal-title":"Mechanobiol. Med."},{"key":"10.1016\/j.bioactmat.2024.05.042_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121599","article-title":"Smart hypoxia-responsive transformable and charge-reversible nanoparticles for the deep penetration and tumor microenvironment modulation of pancreatic cancer","volume":"287","author":"Chen","year":"2022","journal-title":"Biomaterials"},{"issue":"24","key":"10.1016\/j.bioactmat.2024.05.042_bib15","doi-asserted-by":"crossref","first-page":"25205","DOI":"10.1021\/acsnano.3c08409","article-title":"Multi-stimuli-responsive and cell membrane camouflaged aggregation-induced emission nanogels for precise chemo-photothermal synergistic therapy of tumors","volume":"17","author":"Zhang","year":"2023","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.bioactmat.2024.05.042_bib16","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.apsb.2022.05.027","article-title":"A neutrophil-biomimic platform for eradicating metastatic breast cancer stem-like cells by redox microenvironment modulation and hypoxia- triggered differentiation therapy","volume":"13","author":"Chu","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.bioactmat.2024.05.042_bib17","doi-asserted-by":"crossref","first-page":"5634","DOI":"10.1038\/s41467-023-41388-2","article-title":"Dual hypoxia-responsive supramolecular complex for cancer target therapy","volume":"14","author":"Guo","year":"2023","journal-title":"Nat. Commun."},{"issue":"23","key":"10.1016\/j.bioactmat.2024.05.042_bib18","doi-asserted-by":"crossref","first-page":"23223","DOI":"10.1021\/acsnano.3c06019","article-title":"Stimuli-responsive polymer-based nanosystems for cancer theranostics","volume":"17","author":"Wei","year":"2023","journal-title":"ACS Nano"},{"issue":"10","key":"10.1016\/j.bioactmat.2024.05.042_bib19","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrd3554","article-title":"Interfering with pH regulation in tumours as a therapeutic strategy","volume":"10","author":"Neri","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.bioactmat.2024.05.042_bib20","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s13045-022-01358-5","article-title":"Warburg effect in colorectal cancer: The emerging roles in tumor microenvironment and therapeutic implications","volume":"15","author":"Zhong","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.bioactmat.2024.05.042_bib21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrclinonc.2016.60","article-title":"Cancer metabolism: A therapeutic perspective","volume":"14","author":"Martinez-Outschoorn","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.bioactmat.2024.05.042_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.11.043","article-title":"Structural basis of human monocarboxylate transporter 1 inhibition by anti-cancer drug candidates","volume":"184","author":"Wang","year":"2021","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.bioactmat.2024.05.042_bib23","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1016\/j.drudis.2018.05.016","article-title":"Prolyl hydroxylase 2: A promising target to inhibit hypoxia-induced cellular metabolism in cancer cells","volume":"23","author":"Singh","year":"2018","journal-title":"Drug Discov. Today"},{"issue":"2","key":"10.1016\/j.bioactmat.2024.05.042_bib24","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1152\/physrev.1981.61.2.296","volume":"61","author":"Roos","year":"1981","journal-title":"Physiol. Rev."},{"issue":"Suppl 1","key":"10.1016\/j.bioactmat.2024.05.042_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14756360902784425","article-title":"Taking advantage of tumor cell adaptations to hypoxia for developing new tumor markers and treatment strategies","volume":"24","author":"Ebbesen","year":"2009","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioactmat.2024.05.042_bib26","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.semcancer.2008.03.011","article-title":"Adaptation to hypoxia and acidosis in carcinogenesis and tumor progression","volume":"18","author":"Fang","year":"2008","journal-title":"Semin. Cancer Biol."},{"issue":"12","key":"10.1016\/j.bioactmat.2024.05.042_bib27","first-page":"3930","article-title":"Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice","volume":"118","author":"Sonveaux","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bioactmat.2024.05.042_bib28","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1479-5876-8-57","article-title":"Proton dynamics in cancer","volume":"8","author":"Huber","year":"2010","journal-title":"J. Transl. Med."},{"issue":"Suppl. 4","key":"10.1016\/j.bioactmat.2024.05.042_bib29","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1464-410X.2008.07644.x","article-title":"Cancer-associated, hypoxia-inducible carbonic anhydrase IX facilitates CO2 diffusion","volume":"101","author":"Swietach","year":"2008","journal-title":"BJU Int."},{"issue":"7092","key":"10.1016\/j.bioactmat.2024.05.042_bib30","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nature04871","article-title":"Hypoxia signalling in cancer and approaches to enforce tumour regression","volume":"441","author":"Pouyssegur","year":"2006","journal-title":"Nature"},{"issue":"29","key":"10.1016\/j.bioactmat.2024.05.042_bib31","doi-asserted-by":"crossref","first-page":"20473","DOI":"10.1074\/jbc.M801330200","article-title":"Tumor-associated carbonic anhydrase 9 spatially coordinates intracellular pH in three-dimensional multicellular growths","volume":"283","author":"Swietach","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.bioactmat.2024.05.042_bib32","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ccr.2008.05.005","article-title":"Tumor cell metabolism: Cancer\u2019s Achilles\u2019 heel","volume":"13","author":"Kroemer","year":"2008","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.bioactmat.2024.05.042_bib33","first-page":"79","article-title":"Extracellular acidity as favouring factor of tumor progression and metastatic dissemination","volume":"34","author":"Calorini","year":"2012","journal-title":"Exp. Oncol."},{"issue":"21","key":"10.1016\/j.bioactmat.2024.05.042_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202300216","article-title":"A hierarchical structured fiber device remodeling the acidic tumor microenvironment for enhanced cancer immunotherapy","volume":"35","author":"Li","year":"2023","journal-title":"Adv. Mater."},{"issue":"8","key":"10.1016\/j.bioactmat.2024.05.042_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202106654","article-title":"Tumor-microenvironment-activatable polymer nano-immunomodulator for orecision cancer photoimmunotherapy","volume":"34","author":"Liu","year":"2022","journal-title":"Adv. Mater."},{"issue":"6","key":"10.1016\/j.bioactmat.2024.05.042_bib36","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1158\/0008-5472.CAN-08-2394","article-title":"The potential role of systemic buffers in reducing intratumoral extracellular pH and acid-mediated invasion","volume":"69","author":"Silva","year":"2009","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.bioactmat.2024.05.042_bib37","doi-asserted-by":"crossref","DOI":"10.4172\/2161-0444.1000314","article-title":"Systemic buffers in cancer therapy: The example of sodium bicarbonate; stupid idea or wise remedy?","volume":"5","author":"Faes","year":"2015","journal-title":"Med. Chem."},{"issue":"7","key":"10.1016\/j.bioactmat.2024.05.042_bib38","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/sj.bjc.6690455","article-title":"Enhancement of chemotherapy by manipulation of tumour pH","volume":"80","author":"Raghunand","year":"1999","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.bioactmat.2024.05.042_bib39","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1158\/0008-5472.CAN-07-5575","article-title":"Bicarbonate increases tumor pH and inhibits spontaneous metastases","volume":"69","author":"Robey","year":"2009","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.bioactmat.2024.05.042_bib40","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/bjc.2012.58","article-title":"Predicting the safety and efficacy of buffer therapy to raise tumour pHe: An integrative modelling study","volume":"106","author":"Martin","year":"2012","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.bioactmat.2024.05.042_bib41","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41565-018-0319-4","article-title":"In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment","volume":"14","author":"Chen","year":"2019","journal-title":"Nat. Nanotechnol."},{"issue":"25","key":"10.1016\/j.bioactmat.2024.05.042_bib42","doi-asserted-by":"crossref","first-page":"12639","DOI":"10.1039\/C5NR06162H","article-title":"Monodispersed calcium carbonate nanoparticles modulate local pH and inhibit tumor growth in vivo","volume":"8","author":"Som","year":"2016","journal-title":"Nanoscale"},{"issue":"4","key":"10.1016\/j.bioactmat.2024.05.042_bib43","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1021\/nn405773r","article-title":"Multifunctional albumin-MnO2 nanoparticles modulate solid tumor microenvironment by attenuating hypoxia, acidosis, vascular endothelial growth factor and enhance radiation response","volume":"8","author":"Prasad","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioactmat.2024.05.042_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2019.01.004","article-title":"Sodium bicarbonate nanoparticles modulate the tumor pH and enhance the cellular uptake of doxorubicin","volume":"296","author":"Abumanhal-Masarweh","year":"2019","journal-title":"J. Control. Release"},{"issue":"9","key":"10.1016\/j.bioactmat.2024.05.042_bib45","doi-asserted-by":"crossref","first-page":"13884","DOI":"10.1021\/acsnano.2c02688","article-title":"Chemical modulation of glucose metabolism with a fluorinated CaCO3 nanoregulator can potentiate radiotherapy by programming antitumor immunity","volume":"16","author":"Dong","year":"2022","journal-title":"ACS Nano"},{"issue":"3","key":"10.1016\/j.bioactmat.2024.05.042_bib46","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202106520","article-title":"Coordination polymer-coated CaCO3 reinforces radiotherapy by reprogramming the immunosuppressive metabolic microenvironment","volume":"34","author":"Wang","year":"2022","journal-title":"Adv. Mater."},{"issue":"19","key":"10.1016\/j.bioactmat.2024.05.042_bib47","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202100748","article-title":"CaCO3-encapuslated microspheres for enhanced transhepatic arterial embolization treatment of hepatocellular carcinoma","volume":"10","author":"Zhang","year":"2021","journal-title":"Adv. Healthc. Mater."},{"issue":"9","key":"10.1016\/j.bioactmat.2024.05.042_bib48","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202308254","article-title":"Tumor microenvironment modulating CaCO3-based colloidosomal microreactors can generally reinforce cancer immunotherapy","volume":"36","author":"Dong","year":"2024","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.bioactmat.2024.05.042_bib49","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jconrel.2004.11.015","article-title":"Drug-incorporating calcium carbonate nanoparticles for a new delivery system","volume":"103","author":"Ueno","year":"2005","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.bioactmat.2024.05.042_bib50","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.biomaterials.2012.09.068","article-title":"The inhibition of human bladder cancer growth by calcium carbonate\/CaIP6 nanocomposite particles delivering AIB1 siRNA","volume":"34","author":"Wei","year":"2013","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.bioactmat.2024.05.042_bib51","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2217\/nnm-2018-0302","article-title":"Calcium carbonate nanoparticles stimulate tumor metabolic reprogramming and modulate tumor metastasis","volume":"14","author":"Som","year":"2019","journal-title":"Nanomedicine"},{"issue":"11","key":"10.1016\/j.bioactmat.2024.05.042_bib52","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/nrc1478","article-title":"Why do cancers have high aerobic glycolysis?","volume":"4","author":"Gatenby","year":"2004","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.bioactmat.2024.05.042_bib53","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1582-4934.2009.00994.x","article-title":"Tumour hypoxia induces a metabolic shift causing acidosis: A common feature in cancer","volume":"14","author":"Chiche","year":"2010","journal-title":"J. Cell Mol. Med."},{"issue":"4","key":"10.1016\/j.bioactmat.2024.05.042_bib54","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1021\/nn405773r","article-title":"Multifunctional albumin-MnO2 nanoparticles modulate solid tumor microenvironment by attenuating hypoxia, acidosis, vascular endothelial growth factor and enhance radiation response","volume":"8","author":"Prasad","year":"2014","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.bioactmat.2024.05.042_bib55","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.chempr.2021.11.020","article-title":"Nanoscale CaH2 materials for synergistic hydrogen-immune cancer therapy","volume":"8","author":"Gong","year":"2022","journal-title":"Chem"},{"issue":"8","key":"10.1016\/j.bioactmat.2024.05.042_bib56","doi-asserted-by":"crossref","first-page":"12036","DOI":"10.1021\/acsnano.2c02183","article-title":"Efficient immunotherapy of drug-free layered double hydroxide nanoparticles via neutralizing excess acid and blocking tumor cell autophagy","volume":"16","author":"Zhang","year":"2022","journal-title":"ACS Nano"},{"issue":"5","key":"10.1016\/j.bioactmat.2024.05.042_bib57","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1158\/1535-7163.MCT-06-0024","article-title":"Tumor pH controls the in vivo efficacy of weak acid and base chemotherapeutics","volume":"5","author":"Gerweck","year":"2006","journal-title":"Mol. Cancer Therapeut."},{"issue":"1","key":"10.1016\/j.bioactmat.2024.05.042_bib58","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1475-2867-13-89","article-title":"Acidic extracellular microenvironment and cancer","volume":"13","author":"Kato","year":"2013","journal-title":"Cancer Cell Int."},{"issue":"7","key":"10.1016\/j.bioactmat.2024.05.042_bib59","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S0006-2952(03)00467-2","article-title":"Tumor acidity, ion trapping and chemotherapeutics. I. Acid pH affects the distribution of chemotherapeutic agents in vitro","volume":"66","author":"Mahoney","year":"2003","journal-title":"Biochem. Pharmacol."},{"issue":"10 Pt B","key":"10.1016\/j.bioactmat.2024.05.042_bib60","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1016\/j.bbamem.2015.02.004","article-title":"Contribution of acidic extracellular microenvironment of cancer-colonized bone to bone pain","volume":"1848","author":"Yoneda","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"6","key":"10.1016\/j.bioactmat.2024.05.042_bib61","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1021\/mp200292c","article-title":"Drug resistance and cellular adaptation to tumor acidic pH microenvironment","volume":"8","author":"Wojtkowiak","year":"2011","journal-title":"Mol. Pharm."},{"issue":"3191","key":"10.1016\/j.bioactmat.2024.05.042_bib62","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bioactmat.2024.05.042_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/iub.573","article-title":"The monocarboxylate transporter family--Structure and functional characterization","volume":"64","author":"Halestrap","year":"2012","journal-title":"IUBMB Life"},{"issue":"5","key":"10.1016\/j.bioactmat.2024.05.042_bib64","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bioactmat.2024.05.042_bib65","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.semcancer.2008.11.006","article-title":"Hexokinase-2 bound to mitochondria: Cancer\u2019s stygian link to the \u201cWarburg Effect\u201d and a pivotal target for effective therapy","volume":"19","author":"Mathupala","year":"2009","journal-title":"Semin. Cancer Biol."},{"issue":"10","key":"10.1016\/j.bioactmat.2024.05.042_bib66","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1517\/14728222.2013.833607","article-title":"Targeting VDAC-bound hexokinase II: A promising approach for concomitant anti-cancer therapy","volume":"17","author":"Krasnov","year":"2013","journal-title":"Expert Opin. Ther. Targets"},{"issue":"1","key":"10.1016\/j.bioactmat.2024.05.042_bib67","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13046-017-0530-4","article-title":"Benserazide, a dopadecarboxylase inhibitor, suppresses tumor growth by targeting hexokinase 2","volume":"36","author":"Li","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"22","key":"10.1016\/j.bioactmat.2024.05.042_bib68","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.4161\/cc.26461","article-title":"Direct inhibition of hexokinase activity by metformin at least partially impairs glucose metabolism and tumor growth in experimental breast cancer","volume":"12","author":"Marini","year":"2013","journal-title":"Cell Cycle"},{"issue":"9","key":"10.1016\/j.bioactmat.2024.05.042_bib69","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1158\/2159-8290.CD-12-0263","article-title":"Investigating metformin for cancer prevention and treatment: The end of the beginning","volume":"2","author":"Pollak","year":"2012","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bioactmat.2024.05.042_bib70","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1038\/srep02070","article-title":"Metformin impairs glucose consumption and survival in Calu-1 cells by direct inhibition of hexokinase-II","volume":"3","author":"Salani","year":"2013","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.bioactmat.2024.05.042_bib71","doi-asserted-by":"crossref","first-page":"909","DOI":"10.4161\/cc.8.6.7933","article-title":"Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro","volume":"8","author":"Alimova","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bioactmat.2024.05.042_bib72","doi-asserted-by":"crossref","DOI":"10.1038\/srep17423","article-title":"Metformin suppressed the proliferation of LoVo cells and induced a time-dependent metabolic and transcriptional alteration","volume":"5","author":"He","year":"2015","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.bioactmat.2024.05.042_bib73","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1158\/0008-5472.CAN-09-2782","article-title":"Targeting cancer cell metabolism: The combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells","volume":"70","author":"Ben","year":"2010","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.bioactmat.2024.05.042_bib74","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1021\/acs.nanolett.5b04495","article-title":"Single cell \"glucose nanosensor\" verifies elevated glucose levels in individual cancer cells","volume":"16","author":"Nascimento","year":"2016","journal-title":"Nano Lett."},{"issue":"3","key":"10.1016\/j.bioactmat.2024.05.042_bib75","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/jcp.20166","article-title":"Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer","volume":"202","author":"Macheda","year":"2005","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.bioactmat.2024.05.042_bib76","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1172\/JCI63146","article-title":"Increased sugar uptake promotes oncogenesis via EPAC\/RAP1 and O-GlcNAc pathways","volume":"124","author":"Onodera","year":"2014","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.bioactmat.2024.05.042_bib77","doi-asserted-by":"crossref","first-page":"651","DOI":"10.18632\/oncotarget.2892","article-title":"Targeting the facilitative glucose transporter GLUT1 inhibits the self-renewal and tumor-initiating capacity of cancer stem cells","volume":"6","author":"Shibuya","year":"2015","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.bioactmat.2024.05.042_bib78","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nrd4145","article-title":"Metabolic targets for cancer therapy","volume":"12","author":"Galluzzi","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioactmat.2024.05.042_bib79","doi-asserted-by":"crossref","first-page":"e532","DOI":"10.1038\/cddis.2013.60","article-title":"Targeting cellular metabolism to improve cancer therapeutics","volume":"4","author":"Zhao","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bioactmat.2024.05.042_bib80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2015.01.068","article-title":"Targeting glucose uptake with siRNA-based nanomedicine for cancer therapy","volume":"51","author":"Xu","year":"2015","journal-title":"Biomaterials"},{"issue":"8","key":"10.1016\/j.bioactmat.2024.05.042_bib81","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1158\/1535-7163.MCT-12-0131","article-title":"A small-molecule inhibitor of glucose transporter 1 downregulates glycolysis, induces cell-cycle arrest, and inhibits cancer cell growth in vitro and in vivo","volume":"11","author":"Liu","year":"2012","journal-title":"Mol. Cancer Therapeut."},{"issue":"2","key":"10.1016\/j.bioactmat.2024.05.042_bib82","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1021\/acsnano.6b06658","article-title":"Overcoming the heat endurance of tumor cells by interfering with the anaerobic glycolysis metabolism for improved photothermal therapy","volume":"11","author":"Chen","year":"2017","journal-title":"ACS Nano"},{"issue":"11","key":"10.1016\/j.bioactmat.2024.05.042_bib83","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1158\/0008-5472.CAN-11-1272","article-title":"Modulation of microenvironment acidity reverses anergy in human and murine tumor-infiltrating T lymphocytes","volume":"72","author":"Calcinotto","year":"2012","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.bioactmat.2024.05.042_bib84","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1182\/blood-2006-07-035972","article-title":"Inhibitory effect of tumor cell-derived lactic acid on human T cells","volume":"109","author":"Fischer","year":"2007","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.bioactmat.2024.05.042_bib85","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nri.2016.80","article-title":"Regulatory circuits of T cell function in cancer","volume":"16","author":"Speiser","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bioactmat.2024.05.042_bib86","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.semcancer.2017.03.001","article-title":"Cancer acidity: An ultimate frontier of tumor immune escape and a novel target of immunomodulation","volume":"43","author":"Huber","year":"2017","journal-title":"Semin. Cancer Biol."},{"issue":"6","key":"10.1016\/j.bioactmat.2024.05.042_bib87","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1158\/0008-5472.CAN-15-1743","article-title":"Neutralization of tumor acidity Improves antitumor responses to immunotherapy","volume":"76","author":"Pilon-Thomas","year":"2016","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.bioactmat.2024.05.042_bib88","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ccell.2017.02.008","article-title":"Obstacles posed by the tumor microenvironment to T cell activity: A case for synergistic therapies","volume":"31","author":"Anderson","year":"2017","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.bioactmat.2024.05.042_bib89","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nri3175","article-title":"Coordinated regulation of myeloid cells by tumours","volume":"12","author":"Gabrilovich","year":"2012","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.bioactmat.2024.05.042_bib90","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.cmet.2016.12.018","article-title":"Foxp3 reprograms T cell metabolism to function in low-glucose, high-lactate environments","volume":"25","author":"Angelin","year":"2017","journal-title":"Cell Metabol."},{"issue":"5","key":"10.1016\/j.bioactmat.2024.05.042_bib91","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1021\/acs.nanolett.8b04296","article-title":"Nanoenabled modulation of acidic tumor microenvironment reverses anergy of infiltrating T cells and potentiates anti-PD-1 therapy","volume":"19","author":"Zhang","year":"2019","journal-title":"Nano Lett."},{"issue":"5","key":"10.1016\/j.bioactmat.2024.05.042_bib92","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1021\/acs.nanolett.9b00021","article-title":"Reprogramming tumor immune microenvironment (TIME) and metabolism via biomimetic targeting codelivery of shikonin\/JQ1","volume":"19","author":"Wang","year":"2019","journal-title":"Nano Lett."},{"issue":"18","key":"10.1016\/j.bioactmat.2024.05.042_bib93","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1055\/s-0033-1350934","article-title":"Pharmacological properties of shikonin - A review of literature since 2002","volume":"79","author":"Andujar","year":"2013","journal-title":"Planta Med."},{"key":"10.1016\/j.bioactmat.2024.05.042_bib94","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12943-015-0435-9","article-title":"Shikonin-enhanced cell immunogenicity of tumor vaccine is mediated by the differential effects of DAMP components","volume":"14","author":"Lin","year":"2015","journal-title":"Mol. Cancer"},{"issue":"28","key":"10.1016\/j.bioactmat.2024.05.042_bib95","doi-asserted-by":"crossref","first-page":"43629","DOI":"10.18632\/oncotarget.9660","article-title":"Immunogenicity of mammary tumor cells can be induced by shikonin via direct binding-interference with hnRNPA1","volume":"7","author":"Yin","year":"2016","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.bioactmat.2024.05.042_bib96","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1016\/j.celrep.2016.08.032","article-title":"BET bromodomain inhibition promotes anti-tumor immunity by suppressing PD-L1 expression","volume":"16","author":"Zhu","year":"2016","journal-title":"Cell Rep."},{"issue":"8","key":"10.1016\/j.bioactmat.2024.05.042_bib97","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1158\/2159-8290.CD-16-1020","article-title":"Synergistic immunostimulatory effects and therapeutic benefit of combined histone deacetylase and bromodomain inhibition in non-small cell lung cancer","volume":"7","author":"Adeegbe","year":"2017","journal-title":"Cancer Discov."},{"issue":"10","key":"10.1016\/j.bioactmat.2024.05.042_bib98","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1158\/2326-6066.CIR-18-0077","article-title":"BET bromodomain inhibition cooperates with PD-1 blockade to facilitate antitumor response in Kras-mutant non-small cell Lung cancer","volume":"6","author":"Adeegbe","year":"2018","journal-title":"Cancer Immunol. Res."},{"issue":"2","key":"10.1016\/j.bioactmat.2024.05.042_bib99","first-page":"71","article-title":"Effects of ball-milling on PLGA polymer and its implication on lansoprazole-loaded nanoparticles","volume":"2","author":"Shabir","year":"2011","journal-title":"J. Basic Clin. Pharm."},{"key":"10.1016\/j.bioactmat.2024.05.042_bib100","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.colsurfb.2013.06.035","article-title":"A novel nanoparticulate system for sustained delivery of acid-labile lansoprazole","volume":"111","author":"Alai","year":"2013","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"1","key":"10.1016\/j.bioactmat.2024.05.042_bib101","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2174\/156720112798376041","article-title":"Freeze dried chitosan\/poly(glutamic acid) microparticles for intestinal delivery of lansoprazole","volume":"9","author":"Singh","year":"2012","journal-title":"Curr. Drug Deliv."},{"issue":"1","key":"10.1016\/j.bioactmat.2024.05.042_bib102","first-page":"67","article-title":"Discovery of lansoprazole and its unique pharmacological properties independent from anti-secretory activity","volume":"19","author":"Satoh","year":"2013","journal-title":"Curr. Pharmaceut. Des."},{"issue":"9","key":"10.1016\/j.bioactmat.2024.05.042_bib103","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nrc3110","article-title":"Dysregulated pH: A perfect storm for cancer progression","volume":"11","author":"Webb","year":"2011","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.bioactmat.2024.05.042_bib104","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s11033-015-3857-y","article-title":"Introduction to the molecular basis of cancer metabolism and the Warburg effect","volume":"42","author":"Ngo","year":"2015","journal-title":"Mol. Biol. Rep."},{"issue":"2\u20133","key":"10.1016\/j.bioactmat.2024.05.042_bib105","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.mam.2012.05.001","article-title":"SLC9\/NHE gene family, a plasma membrane and organellar family of Na+\/H+ exchangers","volume":"34","author":"Donowitz","year":"2013","journal-title":"Mol. Aspect. Med."},{"issue":"1","key":"10.1016\/j.bioactmat.2024.05.042_bib106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1074\/jbc.275.1.1","article-title":"The expanding family of eucaryotic Na+\/H+ exchangers","volume":"275","author":"Counillon","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bioactmat.2024.05.042_bib107","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.febslet.2004.10.043","article-title":"Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH","volume":"577","author":"Svastova","year":"2004","journal-title":"FEBS Lett."},{"issue":"9","key":"10.1016\/j.bioactmat.2024.05.042_bib108","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrc3579","article-title":"Disrupting proton dynamics and energy metabolism for cancer therapy","volume":"13","author":"Parks","year":"2013","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.bioactmat.2024.05.042_bib109","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1158\/0008-5472.CAN-08-2470","article-title":"Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH","volume":"69","author":"Chiche","year":"2009","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.bioactmat.2024.05.042_bib110","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.3892\/etm.2015.2758","article-title":"Bafilomycin A1 inhibits the growth and metastatic potential of the BEL-7402 liver cancer and HO-8910 ovarian cancer cell lines and induces alterations in their microRNA expression","volume":"10","author":"Lu","year":"2015","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.bioactmat.2024.05.042_bib111","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.semcancer.2016.12.003","article-title":"Value of pH regulators in the diagnosis, prognosis and treatment of cancer","volume":"43","author":"Granja","year":"2017","journal-title":"Semin. Cancer Biol."},{"issue":"4","key":"10.1016\/j.bioactmat.2024.05.042_bib112","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2174\/1574892813666180831102519","article-title":"Recent advances in developing novel anti-cancer drugs targeting tumor hypoxic and acidic microenvironments","volume":"13","author":"Li","year":"2018","journal-title":"Recent Pat. Anticancer Drug Discov."},{"issue":"14","key":"10.1016\/j.bioactmat.2024.05.042_bib113","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1158\/0008-5472.CAN-14-2097","article-title":"Vacuolar-ATPase inhibition blocks iron metabolism to mediate therapeutic effects in breast cancer","volume":"75","author":"Schneider","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioactmat.2024.05.042_bib114","article-title":"DIDS (4,4'-Diisothiocyanatostilbene-2,2'-disulfonate) directly inhibits caspase activity in HeLa cell lysates","volume":"1","author":"Benitez-Rangel","year":"2015","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.bioactmat.2024.05.042_bib115","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.3892\/mmr.2015.3981","article-title":"Effects of salinomycin and CGP37157 on head and neck squamous cell carcinoma cell lines in vitro","volume":"12","author":"Scherzed","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"10","key":"10.1016\/j.bioactmat.2024.05.042_bib116","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.2174\/138161212799504821","article-title":"Intracellular proton pumps as targets in chemotherapy: V-ATPases and cancer","volume":"18","author":"Hernandez","year":"2012","journal-title":"Curr. Pharmaceut. Des."},{"issue":"44","key":"10.1016\/j.bioactmat.2024.05.042_bib117","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.1038\/onc.2012.550","article-title":"Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche","volume":"32","author":"Lock","year":"2013","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.bioactmat.2024.05.042_bib118","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1158\/0008-5472.CAN-10-4261","article-title":"Targeting tumor hypoxia: Suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors","volume":"71","author":"Lou","year":"2011","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.bioactmat.2024.05.042_bib119","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/sj.bjc.6600424","article-title":"Cytostatic potential of novel agents that inhibit the regulation of intracellular pH","volume":"87","author":"Wong","year":"2002","journal-title":"Br. J. Cancer"},{"issue":"13","key":"10.1016\/j.bioactmat.2024.05.042_bib120","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1158\/0008-5472.CAN-15-1862","article-title":"Disrupting hypoxia-induced bicarbonate transport acidifies tumor cells and suppresses tumor growth","volume":"76","author":"McIntyre","year":"2016","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.bioactmat.2024.05.042_bib121","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ctrv.2009.08.003","article-title":"V-ATPase inhibitors and implication in cancer treatment","volume":"35","author":"Perez-Sayans","year":"2009","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.bioactmat.2024.05.042_bib122","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ejpb.2016.09.018","article-title":"Inhibition of carbonic anhydrase IX in glioblastoma multiforme","volume":"109","author":"Amiri","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"14","key":"10.1016\/j.bioactmat.2024.05.042_bib123","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1038\/onc.2013.121","article-title":"Tumor stroma: A complexity dictated by the hypoxic tumor microenvironment","volume":"33","author":"Casazza","year":"2014","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.bioactmat.2024.05.042_bib124","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1007\/s00204-016-1907-4","article-title":"Acidic cellular microenvironment modifies carcinogen-induced DNA damage and repair","volume":"91","author":"Shi","year":"2017","journal-title":"Arch. Toxicol."},{"issue":"5","key":"10.1016\/j.bioactmat.2024.05.042_bib125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1000394","article-title":"Structural adaptation and heterogeneity of normal and tumor microvascular networks","volume":"5","author":"Pries","year":"2009","journal-title":"PLoS Comput. Biol."},{"issue":"Suppl 5","key":"10.1016\/j.bioactmat.2024.05.042_bib126","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1634\/theoncologist.9-90005-4","article-title":"Tumor hypoxia: Causative factors, compensatory mechanisms, and cellular response","volume":"9","author":"Vaupel","year":"2004","journal-title":"Oncologist"},{"key":"10.1016\/j.bioactmat.2024.05.042_bib127","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.semcancer.2015.09.001","article-title":"The mechanical microenvironment in cancer: How physics affects tumours","volume":"35","author":"Nagelkerke","year":"2015","journal-title":"Semin. Cancer Biol."},{"issue":"2","key":"10.1016\/j.bioactmat.2024.05.042_bib128","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00280-014-2635-1","article-title":"Prognostic relevance of carbonic anhydrase IX expression is distinct in various subtypes of breast cancer and its silencing suppresses self-renewal capacity of breast cancer cells","volume":"75","author":"Ivanova","year":"2015","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"4","key":"10.1016\/j.bioactmat.2024.05.042_bib129","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1007\/s13277-014-2838-4","article-title":"Gene and protein expression of glucose transporter 1 and glucose transporter 3 in human laryngeal cancer-the relationship with regulatory hypoxia-inducible factor-1\u03b1 expression, tumor invasiveness, and patient prognosis","volume":"36","author":"Starska","year":"2015","journal-title":"Tumour Biol."},{"issue":"2","key":"10.1016\/j.bioactmat.2024.05.042_bib130","first-page":"101","article-title":"Biology of hypoxia, semin","volume":"45","author":"Span","year":"2015","journal-title":"Nucl. Med."},{"issue":"4","key":"10.1016\/j.bioactmat.2024.05.042_bib131","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/ncb3130","article-title":"Hypoxia-inducible TAp73 supports tumorigenesis by regulating the angiogenic transcriptome","volume":"17","author":"Dulloo","year":"2015","journal-title":"Nat. Cell Biol."},{"issue":"6","key":"10.1016\/j.bioactmat.2024.05.042_bib132","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrc1367","article-title":"Exploiting tumour hypoxia in cancer treatment","volume":"4","author":"Brown","year":"2004","journal-title":"Nat. Rev. Cancer"},{"issue":"6","key":"10.1016\/j.bioactmat.2024.05.042_bib133","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nrc3064","article-title":"Targeting hypoxia in cancer therapy","volume":"11","author":"Wilson","year":"2011","journal-title":"Nat. Rev. Cancer"},{"issue":"6","key":"10.1016\/j.bioactmat.2024.05.042_bib134","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1007\/s10439-016-1578-6","article-title":"Hypoxia-sensitive materials for biomedical applications","volume":"44","author":"Yu","year":"2016","journal-title":"Ann. Biomed. Eng."},{"issue":"31","key":"10.1016\/j.bioactmat.2024.05.042_bib135","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202209799","article-title":"Biodegradable NIR-II pseudo conjugate polymeric nanoparticles amplify photodynamic immunotherapy via alleviation of tumor hypoxia and tumor-associated macrophage reprogramming","volume":"35","author":"Wan","year":"2023","journal-title":"Adv. Mater."},{"issue":"4","key":"10.1016\/j.bioactmat.2024.05.042_bib136","doi-asserted-by":"crossref","first-page":"107738","DOI":"10.1016\/j.cclet.2022.08.018","article-title":"Synergetic treatment of oxygen microcapsules and lenvatinib for enhanced therapy of HCC by alleviating hypoxia condition and activating anti-tumor immunity","volume":"34","author":"Sheng","year":"2023","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.bioactmat.2024.05.042_bib137","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.actbio.2023.05.047","article-title":"Gradient tumor microenvironment-promoted penetrating micelles for hypoxia relief and immunosuppression reversion in pancreatic cancer treatment","volume":"167","author":"Luo","year":"2023","journal-title":"Acta Biomater."},{"issue":"30","key":"10.1016\/j.bioactmat.2024.05.042_bib138","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1002\/adma.201301655","article-title":"Microbubbles from gas-generating perfluorohexane nanoemulsions for targeted temperature-sensitive ultrasonography and synergistic HIFU ablation of tumors","volume":"25","author":"Zhou","year":"2013","journal-title":"Adv. Mater."},{"issue":"28","key":"10.1016\/j.bioactmat.2024.05.042_bib139","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1002\/anie.200200550","article-title":"Injectable microbubbles as contrast agents for diagnostic ultrasound imaging: The key role of perfluorochemicals","volume":"42","author":"Schutt","year":"2003","journal-title":"Angew. Chem. Int. Ed."},{"issue":"9","key":"10.1016\/j.bioactmat.2024.05.042_bib140","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1021\/cr970143c","article-title":"Oxygen carriers (\u201cblood substitutes\u201d)--Raison d\u2019Etre, chemistry, and some physiology","volume":"101","author":"Riess","year":"2001","journal-title":"Chem. Rev."},{"issue":"6","key":"10.1016\/j.bioactmat.2024.05.042_bib141","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1053\/j.ackd.2013.08.004","article-title":"Perfluorocarbon nanoparticles for physiological and molecular imaging and therapy","volume":"20","author":"Chen","year":"2013","journal-title":"Adv. Chron. Kidney Dis."},{"issue":"10","key":"10.1016\/j.bioactmat.2024.05.042_bib142","doi-asserted-by":"crossref","first-page":"6145","DOI":"10.1021\/acs.nanolett.6b02365","article-title":"Ultrasound triggered tumor oxygenation with oxygen-shuttle nanoperfluorocarbon to overcome hypoxia-associated resistance in cancer therapies","volume":"16","author":"Song","year":"2016","journal-title":"Nano Lett."},{"issue":"8","key":"10.1016\/j.bioactmat.2024.05.042_bib143","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1525-1594.2009.00944.x","article-title":"Perfluorocarbon-based oxygen carriers: Review of products and trials","volume":"34","author":"Castro","year":"2010","journal-title":"Artif. Organs"},{"issue":"14","key":"10.1016\/j.bioactmat.2024.05.042_bib144","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1002\/adma.201504617","article-title":"Perfluorocarbon-loaded hollow Bi2Se3 nanoparticles for timely supply of oxygen under near-infrared light to enhance the radiotherapy of cancer","volume":"28","author":"Song","year":"2016","journal-title":"Adv. Mater."},{"issue":"35","key":"10.1016\/j.bioactmat.2024.05.042_bib145","doi-asserted-by":"crossref","first-page":"1701429","DOI":"10.1002\/adma.201701429","article-title":"Erythrocyte-membrane-enveloped perfluorocarbon as nanoscale artificial red blood cells to relieve tumor hypoxia and enhance cancer radiotherapy","volume":"29","author":"Gao","year":"2017","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bioactmat.2024.05.042_bib146","doi-asserted-by":"crossref","first-page":"8785","DOI":"10.1038\/ncomms9785","article-title":"Perfluorocarbon nanoparticles enhance reactive oxygen levels and tumour growth inhibition in photodynamic therapy","volume":"6","author":"Cheng","year":"2015","journal-title":"Nat. Commun."},{"issue":"16","key":"10.1016\/j.bioactmat.2024.05.042_bib147","doi-asserted-by":"crossref","first-page":"6851","DOI":"10.1158\/0008-5472.CAN-08-0718","article-title":"Platelet granule secretion continuously prevents intratumor hemorrhage","volume":"68","author":"Ho-Tin-Noe","year":"2008","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.bioactmat.2024.05.042_bib148","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/s41551-017-0115-8","article-title":"Nanoparticle-mediated local depletion of tumour-associated platelets disrupts vascular barriers and augments drug accumulation in tumours","volume":"1","author":"Li","year":"2017","journal-title":"Nat. Biomed. Eng."},{"issue":"18","key":"10.1016\/j.bioactmat.2024.05.042_bib149","doi-asserted-by":"crossref","first-page":"4898","DOI":"10.7150\/thno.27598","article-title":"Two-stage oxygen delivery for enhanced radiotherapy by perfluorocarbon nanoparticles","volume":"8","author":"Zhou","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.bioactmat.2024.05.042_bib150","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.biomaterials.2016.10.020","article-title":"TaOx decorated perfluorocarbon nanodroplets as oxygen reservoirs to overcome tumor hypoxia and enhance cancer radiotherapy","volume":"112","author":"Song","year":"2017","journal-title":"Biomaterials"},{"issue":"29","key":"10.1016\/j.bioactmat.2024.05.042_bib151","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202201978","article-title":"An NIR-II photothermally triggered \u201cOxygen Bomb\u201d for hypoxic tumor programmed cascade therapy","volume":"34","author":"Zhang","year":"2022","journal-title":"Adv. Mater."},{"issue":"8","key":"10.1016\/j.bioactmat.2024.05.042_bib152","article-title":"Mitochondria-targeted artificial \"Nano-RBCs\" for amplified synergistic cancer phototherapy by a single NIR irradiation","volume":"5","author":"Zhang","year":"2018","journal-title":"Adv. Sci."},{"issue":"2","key":"10.1016\/j.bioactmat.2024.05.042_bib153","doi-asserted-by":"crossref","DOI":"10.1117\/1.JBO.22.2.025002","article-title":"Theoretical model for optical oximetry at the capillary level: Exploring hemoglobin oxygen saturation through backscattering of single red blood cells","volume":"22","author":"Liu","year":"2017","journal-title":"J. Biomed. Opt."},{"issue":"3","key":"10.1016\/j.bioactmat.2024.05.042_bib154","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1364\/AO.56.000439","article-title":"Effects of acute hypoxic exposure on oxygen affinity of human red blood cells","volume":"56","author":"Chowdhury","year":"2017","journal-title":"Appl. Opt."},{"issue":"7331","key":"10.1016\/j.bioactmat.2024.05.042_bib155","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nature09702","article-title":"Circadian clocks in human red blood cells","volume":"469","author":"O'Neill","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bioactmat.2024.05.042_bib156","doi-asserted-by":"crossref","first-page":"131420","DOI":"10.1016\/j.cej.2021.131420","article-title":"Metal ions-mediated self-assembly of nanomedicine for combinational therapy against triple-negative breast cancer","volume":"425","author":"Shang","year":"2021","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.bioactmat.2024.05.042_bib157","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.2147\/IJN.S173914","article-title":"Advanced nanomaterials targeting hypoxia to enhance radiotherapy","volume":"13","author":"Li","year":"2018","journal-title":"Int. J. Nanomed."},{"issue":"11","key":"10.1016\/j.bioactmat.2024.05.042_bib158","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/adfm.201504803","article-title":"Red blood cell-facilitated photodynamic therapy for cancer treatment","volume":"26","author":"Wei","year":"2016","journal-title":"Adv. Funct. Mater."},{"issue":"28","key":"10.1016\/j.bioactmat.2024.05.042_bib159","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.1002\/adma.201400158","article-title":"Multifunctional theranostic red blood cells for magnetic-field-enhanced in vivo combination therapy of cancer","volume":"26","author":"Wang","year":"2014","journal-title":"Adv. Mater."},{"issue":"9","key":"10.1016\/j.bioactmat.2024.05.042_bib160","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1021\/acs.biomac.5b00571","article-title":"Synthesis of hemoglobin conjugated polymeric micelle: A ZnPc carrier with oxygen self-compensating ability for photodynamic therapy","volume":"16","author":"Wang","year":"2015","journal-title":"Biomacromolecules"},{"issue":"8","key":"10.1016\/j.bioactmat.2024.05.042_bib161","doi-asserted-by":"crossref","first-page":"8633","DOI":"10.1021\/acsnano.8b04371","article-title":"Bioinspired hybrid protein oxygen nanocarrier amplified photodynamic therapy for eliciting anti-tumor immunity and abscopal effect","volume":"12","author":"Chen","year":"2018","journal-title":"ACS Nano"},{"issue":"1\u20132","key":"10.1016\/j.bioactmat.2024.05.042_bib162","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ijpharm.2009.05.058","article-title":"Ultrasound-mediated oxygen delivery from chitosan nanobubbles","volume":"378","author":"Cavalli","year":"2009","journal-title":"Int. J. Pharm."},{"issue":"20","key":"10.1016\/j.bioactmat.2024.05.042_bib163","doi-asserted-by":"crossref","first-page":"15726","DOI":"10.1021\/la1029432","article-title":"Phospholipid-stabilized microbubble foam for injectable oxygen delivery","volume":"26","author":"Swanson","year":"2010","journal-title":"Langmuir"},{"issue":"1","key":"10.1016\/j.bioactmat.2024.05.042_bib164","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ijpharm.2014.11.023","article-title":"Development of an ultrasound sensitive oxygen carrier for oxygen delivery to hypoxic tissue","volume":"478","author":"Eisenbrey","year":"2015","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.bioactmat.2024.05.042_bib165","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.7314\/APJCP.2012.13.6.2681","article-title":"Relationship between PTEN and Livin expression and malignancy of renal cell carcinomas","volume":"13","author":"Cheng","year":"2012","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"12","key":"10.1016\/j.bioactmat.2024.05.042_bib166","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.7150\/thno.4410","article-title":"Theranostic oxygen delivery using ultrasound and microbubbles","volume":"2","author":"Kwan","year":"2012","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.bioactmat.2024.05.042_bib167","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1080\/10717544.2018.1507062","article-title":"Dual-mode imaging and therapeutic effects of drug-loaded phase-transition nanoparticles combined with near-infrared laser and low-intensity ultrasound on ovarian cancer","volume":"25","author":"Chen","year":"2018","journal-title":"Drug Deliv."},{"issue":"12","key":"10.1016\/j.bioactmat.2024.05.042_bib168","doi-asserted-by":"crossref","first-page":"12849","DOI":"10.1021\/acsnano.7b08225","article-title":"Oxygen-self-produced nanoplatform for relieving hypoxia and breaking resistance to Sonodynamic treatment of pancreatic cancer","volume":"11","author":"Chen","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioactmat.2024.05.042_bib169","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jconrel.2016.11.006","article-title":"Drug-induced co-assembly of albumin\/catalase as smart nano-theranostics for deep intra-tumoral penetration, hypoxia relieve, and synergistic combination therapy","volume":"263","author":"Chen","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioactmat.2024.05.042_bib170","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.actbio.2020.05.035","article-title":"Oxygen-producing catalase-based prodrug nanoparticles overcoming resistance in hypoxia-mediated chemo-photodynamic therapy","volume":"112","author":"Cheng","year":"2020","journal-title":"Acta Biomater."},{"issue":"4","key":"10.1016\/j.bioactmat.2024.05.042_bib171","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1021\/ja511420n","article-title":"H2O2-activatable and O2-evolving nanoparticles for highly efficient and selective photodynamic therapy against hypoxic tumor cells","volume":"137","author":"Chen","year":"2015","journal-title":"J. Am. Chem. Soc."},{"issue":"6","key":"10.1016\/j.bioactmat.2024.05.042_bib172","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1039\/C9SC06337D","article-title":"An intelligent ZIF-8-gated polydopamine nanoplatform for in vivo cooperatively enhanced combination phototherapy","volume":"11","author":"Feng","year":"2020","journal-title":"Chem. Sci."},{"issue":"9","key":"10.1016\/j.bioactmat.2024.05.042_bib173","doi-asserted-by":"crossref","first-page":"11225","DOI":"10.1021\/acsnano.0c03080","article-title":"Surface-charge-switchable nanoclusters for magnetic resonance imaging-guided and glutathione depletion-enhanced photodynamic therapy","volume":"14","author":"Zhu","year":"2020","journal-title":"ACS Nano"},{"issue":"48","key":"10.1016\/j.bioactmat.2024.05.042_bib174","doi-asserted-by":"crossref","first-page":"19278","DOI":"10.1021\/ja2073824","article-title":"Hydrogen peroxide inducible DNA cross-linking agents: Targeted anticancer prodrugs","volume":"133","author":"Kuang","year":"2011","journal-title":"J. Am. Chem. Soc."},{"issue":"3","key":"10.1016\/j.bioactmat.2024.05.042_bib175","first-page":"794","article-title":"Production of large amounts of hydrogen peroxide by human tumor cells","volume":"51","author":"Szatrowski","year":"1991","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.bioactmat.2024.05.042_bib176","doi-asserted-by":"crossref","first-page":"6360","DOI":"10.1021\/acs.nanolett.8b02720","article-title":"Self-supplied tumor oxygenation through separated liposomal delivery of H2O2 and catalase for enhanced radio-immunotherapy of cancer","volume":"18","author":"Song","year":"2018","journal-title":"Nano Lett."},{"issue":"6","key":"10.1016\/j.bioactmat.2024.05.042_bib177","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1039\/C9NR08930F","article-title":"Biomineralization-inspired nanozyme for single-wavelength laser activated photothermal-photodynamic synergistic treatment against hypoxic tumors","volume":"12","author":"Xu","year":"2020","journal-title":"Nanoscale"},{"issue":"31","key":"10.1016\/j.bioactmat.2024.05.042_bib178","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202203734","article-title":"Composition-dependent enzyme mimicking activity and radiosensitizing effect of bimetallic clusters to modulate tumor hypoxia for enhanced cancer therapy","volume":"34","author":"Hua","year":"2022","journal-title":"Adv. Mater."},{"issue":"8","key":"10.1016\/j.bioactmat.2024.05.042_bib179","doi-asserted-by":"crossref","first-page":"9662","DOI":"10.1021\/acsnano.0c00910","article-title":"Hollow magnetic nanocatalysts drive starvation-chemodynamic-hyperthermia synergistic therapy for tumor","volume":"14","author":"Ying","year":"2020","journal-title":"ACS Nano"},{"issue":"8","key":"10.1016\/j.bioactmat.2024.05.042_bib180","article-title":"Biomimetic liposomal nanoplatinum for targeted cancer chemophototherapy","volume":"8","author":"Liu","year":"2021","journal-title":"Adv. Sci."},{"issue":"22","key":"10.1016\/j.bioactmat.2024.05.042_bib181","doi-asserted-by":"crossref","first-page":"6643","DOI":"10.1158\/0008-5472.CAN-15-3475","article-title":"Hybrid manganese dioxide nanoparticles potentiate radiation therapy by modulating tumor hypoxia","volume":"76","author":"Abbasi","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioactmat.2024.05.042_bib182","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3389\/fchem.2017.00109","article-title":"Redox-responsive manganese dioxide nanoparticles for enhanced MR imaging and radiotherapy of lung cancer","volume":"5","author":"Cho","year":"2017","journal-title":"Front. Chem."},{"issue":"5","key":"10.1016\/j.bioactmat.2024.05.042_bib183","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.scib.2017.02.001","article-title":"A smart photodynamic therapy strategy: Depletion of glutathione in cancer cells","volume":"62","author":"Huang","year":"2017","journal-title":"Sci. Bull."},{"issue":"25","key":"10.1016\/j.bioactmat.2024.05.042_bib184","doi-asserted-by":"crossref","first-page":"1700640","DOI":"10.1002\/smll.201700640","article-title":"Albumin-templated manganese dioxide nanoparticles for enhanced radioisotope therapy","volume":"13","author":"Tian","year":"2017","journal-title":"Small"},{"issue":"4","key":"10.1016\/j.bioactmat.2024.05.042_bib185","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1021\/acs.bioconjchem.8b00068","article-title":"Enhanced cellular ablation by attenuating hypoxia status and reprogramming tumor-associated macrophages via NIR light-responsive upconversion nanocrystals","volume":"29","author":"Ai","year":"2018","journal-title":"Bioconjugate Chem."},{"issue":"1","key":"10.1016\/j.bioactmat.2024.05.042_bib186","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1021\/acsnano.5b06779","article-title":"Bioconjugated manganese dioxide nanoparticles enhance chemotherapy response by priming tumor-associated macrophages toward M1-like phenotype and attenuating tumor hypoxia","volume":"10","author":"Song","year":"2016","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.bioactmat.2024.05.042_bib187","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/s41467-017-01050-0","article-title":"Hollow MnO2 as a tumor-microenvironment-responsive biodegradable nano-platform for combination therapy favoring antitumor immune responses","volume":"8","author":"Yang","year":"2017","journal-title":"Nat. Commun."},{"issue":"28","key":"10.1016\/j.bioactmat.2024.05.042_bib188","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.1002\/adma.201405141","article-title":"Intelligent MnO2 nanosheets anchored with upconversion nanoprobes for concurrent pH-\/H2O2-responsive UCL imaging and oxygen-elevated synergetic therapy","volume":"27","author":"Fan","year":"2015","journal-title":"Adv. Mater."},{"issue":"33","key":"10.1016\/j.bioactmat.2024.05.042_bib189","doi-asserted-by":"crossref","first-page":"7129","DOI":"10.1002\/adma.201601902","article-title":"Intelligent albumin-MnO2 nanoparticles as pH-\/H2O2-responsive dissociable nanocarriers to modulate tumor hypoxia for effective combination therapy","volume":"28","author":"Chen","year":"2016","journal-title":"Adv. Mater."},{"issue":"4","key":"10.1016\/j.bioactmat.2024.05.042_bib190","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1021\/acsnano.8b00999","article-title":"Nanoenzyme-augmented cancer sonodynamic therapy by catalytic tumor oxygenation","volume":"12","author":"Zhu","year":"2018","journal-title":"ACS Nano"},{"issue":"9","key":"10.1016\/j.bioactmat.2024.05.042_bib191","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/adfm.200901581","article-title":"Glucose\u2010responsive bioinorganic nanohybrid membrane for self\u2010regulated insulin release","volume":"20","author":"Gordijo","year":"2010","journal-title":"Adv. Funct. Mater."},{"issue":"10","key":"10.1016\/j.bioactmat.2024.05.042_bib192","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.bios.2003.11.019","article-title":"A novel glucose ENFET based on the special reactivity of MnO2 nanoparticles","volume":"19","author":"Luo","year":"2004","journal-title":"Biosens. Bioelectron."},{"issue":"26","key":"10.1016\/j.bioactmat.2024.05.042_bib193","doi-asserted-by":"crossref","first-page":"5255","DOI":"10.1039\/D1TB01009C","article-title":"Oxygen-producing proenzyme hydrogels for photodynamic-mediated metastasis-inhibiting combinational therapy","volume":"9","author":"Liu","year":"2021","journal-title":"J. Mater. Chem. B"},{"issue":"10","key":"10.1016\/j.bioactmat.2024.05.042_bib194","doi-asserted-by":"crossref","first-page":"13894","DOI":"10.1021\/acsnano.0c06290","article-title":"A Smart nanoparticle-laden and remote-controlled self-destructive macrophage for enhanced chemo\/chemodynamic synergistic therapy","volume":"14","author":"Sun","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioactmat.2024.05.042_bib195","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2021.111852","article-title":"Photo-induced tumor therapy using MnO2\/IrO2-PVP nano-enzyme with TME-responsive behaviors","volume":"205","author":"Li","year":"2021","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"12","key":"10.1016\/j.bioactmat.2024.05.042_bib196","doi-asserted-by":"crossref","first-page":"4090","DOI":"10.1039\/C7NR00534B","article-title":"Photocatalytic oxygen evolution from low-bandgap conjugated microporous polymer nanosheets: A combined first-principles calculation and experimental study","volume":"9","author":"Wang","year":"2017","journal-title":"Nanoscale"},{"issue":"38","key":"10.1016\/j.bioactmat.2024.05.042_bib197","doi-asserted-by":"crossref","first-page":"1702428","DOI":"10.1002\/adma.201702428","article-title":"Conjugated microporous polymer nanosheets for overall water splitting using visible light","volume":"29","author":"Wang","year":"2017","journal-title":"Adv. Mater."},{"issue":"9","key":"10.1016\/j.bioactmat.2024.05.042_bib198","doi-asserted-by":"crossref","first-page":"8715","DOI":"10.1021\/acsnano.6b04156","article-title":"Carbon-dot-decorated carbon nitride nanoparticles for rnhanced photodynamic therapy against hypoxic tumor via water splitting","volume":"10","author":"Zheng","year":"2016","journal-title":"ACS Nano"},{"issue":"6","key":"10.1016\/j.bioactmat.2024.05.042_bib199","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1021\/acs.nanolett.9b01458","article-title":"Tumor reoxygenation and blood perfusion enhanced photodynamic therapy using ultrathin graphdiyne oxide nanosheets","volume":"19","author":"Jiang","year":"2019","journal-title":"Nano Lett."},{"issue":"11","key":"10.1016\/j.bioactmat.2024.05.042_bib200","doi-asserted-by":"crossref","first-page":"6973","DOI":"10.1021\/acscatal.5b02185","article-title":"Enhanced driving force and charge separation efficiency of protonated g-C3N4 for photocatalytic O2 evolution","volume":"5","author":"Ye","year":"2015","journal-title":"ACS Catal."},{"issue":"3","key":"10.1016\/j.bioactmat.2024.05.042_bib201","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1039\/C0EE00418A","article-title":"Sulfur-mediated synthesis of carbon nitride: Band-gap engineering and improved functions for photocatalysis","volume":"4","author":"Zhang","year":"2011","journal-title":"Energy Environ. Sci."},{"issue":"12","key":"10.1016\/j.bioactmat.2024.05.042_bib202","doi-asserted-by":"crossref","first-page":"12721","DOI":"10.1021\/acsnano.8b07749","article-title":"Oxygen production of modified core-shell CuO@ZrO2 nanocomposites by microwave radiation to alleviate cancer hypoxia for enhanced chemo-microwave thermal therapy","volume":"12","author":"Chen","year":"2018","journal-title":"ACS Nano"},{"issue":"5","key":"10.1016\/j.bioactmat.2024.05.042_bib203","doi-asserted-by":"crossref","first-page":"5306","DOI":"10.1021\/acsnano.8b09786","article-title":"Gold cube-in-cube based oxygen nanogenerator: A theranostic nanoplatform for modulating tumor microenvironment for precise chemo-phototherapy and multimodal imaging","volume":"13","author":"Zhang","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioactmat.2024.05.042_bib204","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jconrel.2017.09.004","article-title":"Oxygen generating nanoparticles for improved photodynamic therapy of hypoxic tumours","volume":"264","author":"Sheng","year":"2017","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.bioactmat.2024.05.042_bib205","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1007\/s12274-016-1274-8","article-title":"Liposomes co-loaded with metformin and chlorin e6 modulate tumor hypoxia during enhanced photodynamic therapy","volume":"10","author":"Song","year":"2017","journal-title":"Nano Res."},{"issue":"26","key":"10.1016\/j.bioactmat.2024.05.042_bib206","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201700278","article-title":"Self-supplying O2 through the catalase-like activity of gold nanoclusters for photodynamic therapy against hypoxic cancer cells","volume":"13","author":"Liu","year":"2017","journal-title":"Small"},{"issue":"9","key":"10.1016\/j.bioactmat.2024.05.042_bib207","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3928\/02793695-20130805-01","article-title":"A \"glucose eater\" drug as a therapeutic agent in psychiatry","volume":"51","author":"Howland","year":"2013","journal-title":"J. Psychosoc. Nurs. Ment. Health Serv."},{"key":"10.1016\/j.bioactmat.2024.05.042_bib208","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.biomaterials.2016.06.030","article-title":"A novel cationic lipid with intrinsic antitumor activity to facilitate gene therapy of TRAIL DNA","volume":"102","author":"Luo","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioactmat.2024.05.042_bib209","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/ncomms1786","article-title":"Cancer cells that survive radiation therapy acquire HIF-1 activity and translocate towards tumour blood vessels","volume":"3","author":"Harada","year":"2012","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.bioactmat.2024.05.042_bib210","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrc3007","article-title":"Strategies to improve radiotherapy with targeted drugs","volume":"11","author":"Begg","year":"2011","journal-title":"Nat. Rev. Cancer"},{"issue":"7","key":"10.1016\/j.bioactmat.2024.05.042_bib211","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nrc3958","article-title":"The tumour microenvironment after radiotherapy: Mechanisms of resistance and recurrence","volume":"15","author":"Barker","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bioactmat.2024.05.042_bib212","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ultsonch.2015.08.009","article-title":"Ultrasound-mediated destruction of oxygen and paclitaxel loaded lipid microbubbles for combination therapy in hypoxic ovarian cancer cells","volume":"28","author":"Sun","year":"2016","journal-title":"Ultrason. Sonochem."},{"key":"10.1016\/j.bioactmat.2024.05.042_bib213","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2018.02.041","article-title":"Perfluorooctyl bromide & indocyanine green co-loaded nanoliposomes for enhanced multimodal imaging-guided phototherapy","volume":"165","author":"Sheng","year":"2018","journal-title":"Biomaterials"},{"issue":"10","key":"10.1016\/j.bioactmat.2024.05.042_bib214","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for cancer therapy","volume":"3","author":"Semenza","year":"2003","journal-title":"Nat. Rev. Cancer"},{"issue":"12","key":"10.1016\/j.bioactmat.2024.05.042_bib215","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.trecan.2016.10.016","article-title":"Hypoxia-inducible factors: Master regulators of cancer progression","volume":"2","author":"Schito","year":"2016","journal-title":"Trends Cancer"},{"issue":"7","key":"10.1016\/j.bioactmat.2024.05.042_bib216","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.trecan.2017.05.002","article-title":"Targeting hypoxia-inducible factors for antiangiogenic cancer therapy","volume":"3","author":"Rey","year":"2017","journal-title":"Trends Cancer"},{"issue":"8","key":"10.1016\/j.bioactmat.2024.05.042_bib217","doi-asserted-by":"crossref","first-page":"8308","DOI":"10.1021\/acsnano.8b03590","article-title":"Tumor oxygenation and hypoxia inducible factor-1 functional inhibition via a reactive oxygen species responsive nanoplatform for enhancing radiation therapy and abscopal effects","volume":"12","author":"Meng","year":"2018","journal-title":"ACS Nano"},{"issue":"3","key":"10.1016\/j.bioactmat.2024.05.042_bib218","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3349\/ymj.2017.58.3.489","article-title":"Development of inhibitors targeting hypoxia-inducible factor 1 and 2 for cancer therapy","volume":"58","author":"Yu","year":"2017","journal-title":"Yonsei Med. J."},{"issue":"1","key":"10.1016\/j.bioactmat.2024.05.042_bib219","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ccr.2004.06.009","article-title":"Small molecule blockade of transcriptional coactivation of the hypoxia-inducible factor pathway","volume":"6","author":"Kung","year":"2004","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.bioactmat.2024.05.042_bib220","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00280-010-1500-0","article-title":"Antitumor agent PX-12 inhibits HIF-1\u03b1 protein levels through an Nrf2\/PMF-1-mediated increase in spermidine\/spermine acetyl transferase","volume":"68","author":"Kim","year":"2011","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"11","key":"10.1016\/j.bioactmat.2024.05.042_bib221","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1093\/annonc\/mdx493","article-title":"A randomized phase II trial of CRLX101 in combination with bevacizumab versus standard of care in patients with advanced renal cell carcinoma","volume":"28","author":"Voss","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bioactmat.2024.05.042_bib222","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2015.01.002","article-title":"Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity","volume":"91","author":"Maeda","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"14","key":"10.1016\/j.bioactmat.2024.05.042_bib223","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1073\/pnas.1603018113","article-title":"CRLX101 nanoparticles localize in human tumors and not in adjacent, nonneoplastic tissue after intravenous dosing","volume":"113","author":"Clark","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.bioactmat.2024.05.042_bib224","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1535-6108(04)00115-1","article-title":"Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: Role of reoxygenation, free radicals, and stress granules","volume":"5","author":"Moeller","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bioactmat.2024.05.042_bib225","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/978-1-4939-3148-4_12","article-title":"Hypoxia-responsive copolymer for siRNA delivery","volume":"1372","author":"Perche","year":"2016","journal-title":"Methods Mol. Biol."},{"issue":"2","key":"10.1016\/j.bioactmat.2024.05.042_bib226","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1021\/ml3004632","article-title":"Discovery of indenopyrazoles as a new class of hypoxia inducible factor (HIF)-1 inhibitors","volume":"4","author":"Minegishi","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"issue":"4","key":"10.1016\/j.bioactmat.2024.05.042_bib227","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1158\/0008-5472.CAN-03-2698","article-title":"Hypoxia targeted gene therapy to increase the efficacy of tirapazamine as an adjuvant to radiotherapy: Reversing tumor radioresistance and effecting cure","volume":"64","author":"Cowen","year":"2004","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.bioactmat.2024.05.042_bib228","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1021\/mp300193f","article-title":"Therapeutic delivery of siRNA silencing HIF-1\u03b1 with micellar nanoparticles inhibits hypoxic tumor growth","volume":"9","author":"Liu","year":"2012","journal-title":"Mol. Pharm."},{"issue":"7","key":"10.1016\/j.bioactmat.2024.05.042_bib229","doi-asserted-by":"crossref","first-page":"7164","DOI":"10.1021\/acsnano.7b03037","article-title":"Polyoxometalate-based radiosensitization platform for treating hypoxic tumors by Aatenuating radioresistance and enhancing radiation response","volume":"11","author":"Yong","year":"2017","journal-title":"ACS Nano"},{"issue":"15","key":"10.1016\/j.bioactmat.2024.05.042_bib230","doi-asserted-by":"crossref","first-page":"8114","DOI":"10.1021\/acsami.5b00851","article-title":"Enhanced therapeutic siRNA to tumor cells by a pH-sensitive agmatine-chitosan bioconjugate","volume":"7","author":"Li","year":"2015","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"1","key":"10.1016\/j.bioactmat.2024.05.042_bib231","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jconrel.2013.08.005","article-title":"Chitosan-based siRNA delivery systems","volume":"172","author":"Ragelle","year":"2013","journal-title":"J. Control. Release"},{"issue":"8","key":"10.1016\/j.bioactmat.2024.05.042_bib232","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1016\/j.biomaterials.2009.11.067","article-title":"Anti-HIF-1\u03b1 antibody-conjugated pluronic triblock copolymers encapsulated with Paclitaxel for tumor targeting therapy","volume":"31","author":"Song","year":"2010","journal-title":"Biomaterials"},{"issue":"7","key":"10.1016\/j.bioactmat.2024.05.042_bib233","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1021\/acs.nanolett.0c00757","article-title":"Dual hypoxia-targeting RNAi nanomedicine for precision cancer therapy","volume":"20","author":"Li","year":"2020","journal-title":"Nano Lett."},{"issue":"33","key":"10.1016\/j.bioactmat.2024.05.042_bib381","doi-asserted-by":"crossref","first-page":"7143","DOI":"10.1002\/adma.201602111","article-title":"Catalase-loaded TaOx nanoshells as bio-nanoreactors combining high-Z element and enzyme delivery for enhancing radiotherapy","volume":"28","author":"Song","year":"2016","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bioactmat.2024.05.042_bib234","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.biomaterials.2018.08.011","article-title":"Photosensitizer-crosslinked in-situ polymerization on catalase for tumor hypoxia modulation & enhanced photodynamic therapy","volume":"181","author":"Wang","year":"2018","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.bioactmat.2024.05.042_bib235","doi-asserted-by":"crossref","first-page":"4742","DOI":"10.1021\/acsnano.9b01087","article-title":"Catalase-integrated hyaluronic acid as nanocarriers for enhanced photodynamic therapy in solid tumor","volume":"13","author":"Phua","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioactmat.2024.05.042_bib236","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.nano.2019.03.007","article-title":"O2-evolving and ROS-activable nanoparticles for treatment of multi-drug resistant cancer by combination of photodynamic therapy and chemotherapy","volume":"19","author":"Luo","year":"2019","journal-title":"Nanomedicine"},{"issue":"24","key":"10.1016\/j.bioactmat.2024.05.042_bib237","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201900927","article-title":"Light-triggered in situ gelation to enable robust photodynamic-immunotherapy by repeated stimulations","volume":"31","author":"Meng","year":"2019","journal-title":"Adv. Mater."},{"issue":"46","key":"10.1016\/j.bioactmat.2024.05.042_bib238","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201903628","article-title":"Hybrid protein nano-reactors enable simultaneous increments of tumor oxygenation and Iodine-131 delivery for enhanced radionuclide therapy","volume":"15","author":"Chen","year":"2019","journal-title":"Small"},{"issue":"2","key":"10.1016\/j.bioactmat.2024.05.042_bib239","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1021\/acsnano.9b06689","article-title":"Fluorinated chitosan to enhance transmucosal delivery of sonosensitizer-conjugated catalase for sonodynamic bladder cancer treatment post-intravesical instillation","volume":"14","author":"Li","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioactmat.2024.05.042_bib240","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.biomaterials.2017.05.025","article-title":"Catalase-loaded cisplatin-prodrug-constructed liposomes to overcome tumor hypoxia for enhanced chemo-radiotherapy of cancer","volume":"138","author":"Zhang","year":"2017","journal-title":"Biomaterials"},{"issue":"18","key":"10.1016\/j.bioactmat.2024.05.042_bib241","doi-asserted-by":"crossref","first-page":"15494","DOI":"10.1021\/acsami.8b03238","article-title":"Upconversion composite nanoparticles for tumor hypoxia modulation and enhanced near-infrared-triggered photodynamic therapy","volume":"10","author":"Gu","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"39","key":"10.1016\/j.bioactmat.2024.05.042_bib242","doi-asserted-by":"crossref","first-page":"14826","DOI":"10.1039\/C7NR05316A","article-title":"Albumin-templated biomineralizing growth of composite nanoparticles as smart nanotheranostics for enhanced radiotherapy of tumors","volume":"9","author":"Chen","year":"2017","journal-title":"Nanoscale"},{"issue":"11","key":"10.1016\/j.bioactmat.2024.05.042_bib243","doi-asserted-by":"crossref","first-page":"5114","DOI":"10.1039\/C7NR08747K","article-title":"Nano-graphene oxide-manganese dioxide nanocomposites for overcoming tumor hypoxia and enhancing cancer radioisotope therapy","volume":"10","author":"Tao","year":"2018","journal-title":"Nanoscale"},{"issue":"35","key":"10.1016\/j.bioactmat.2024.05.042_bib244","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1039\/C9CC01386E","article-title":"A cancer cell membrane-encapsulated MnO2 nanoreactor for combined photodynamic-starvation therapy","volume":"55","author":"Pan","year":"2019","journal-title":"Chem. Commun."},{"issue":"22","key":"10.1016\/j.bioactmat.2024.05.042_bib245","doi-asserted-by":"crossref","first-page":"19782","DOI":"10.1021\/acsami.9b03889","article-title":"In situ oxygenic nanopods targeting tumor adaption to hypoxia potentiate image-guided photothermal therapy","volume":"11","author":"Revuri","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"72","key":"10.1016\/j.bioactmat.2024.05.042_bib246","doi-asserted-by":"crossref","first-page":"10792","DOI":"10.1039\/C9CC05107D","article-title":"Photodynamic therapy for hypoxic solid tumors via Mn-MOF as a photosensitizer","volume":"55","author":"Lu","year":"2019","journal-title":"Chem. Commun."},{"key":"10.1016\/j.bioactmat.2024.05.042_bib247","doi-asserted-by":"crossref","first-page":"109979","DOI":"10.1016\/j.msec.2019.109979","article-title":"Investigation of PPIX-Lipo-MnO2 to enhance photodynamic therapy by improving tumor hypoxia","volume":"104","author":"Chudal","year":"2019","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"issue":"49","key":"10.1016\/j.bioactmat.2024.05.042_bib248","doi-asserted-by":"crossref","first-page":"1904979","DOI":"10.1002\/smll.201904979","article-title":"Nanoparticle-embedded electrospun fiber-covered stent to assist intraluminal photodynamic treatment of oesophageal cancer","volume":"15","author":"Xiao","year":"2019","journal-title":"Small"},{"issue":"7","key":"10.1016\/j.bioactmat.2024.05.042_bib249","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.1021\/acs.nanolett.9b00934","article-title":"Biomimetic hybrid nanozymes with self-supplied H+ and accelerated O2 generation for enhanced starvation and photodynamic therapy against hypoxic tumors","volume":"19","author":"Yang","year":"2019","journal-title":"Nano Lett."},{"issue":"34","key":"10.1016\/j.bioactmat.2024.05.042_bib250","doi-asserted-by":"crossref","first-page":"5170","DOI":"10.1039\/C9TB00991D","article-title":"Intelligent protein-coated bismuth sulfide and manganese oxide nanocomposites obtained by biomineralization for multimodal imaging-guided enhanced tumor therapy","volume":"7","author":"Zhang","year":"2019","journal-title":"J. Mater. Chem. B"},{"issue":"1","key":"10.1016\/j.bioactmat.2024.05.042_bib251","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1021\/acsnano.7b07746","article-title":"Nanozyme decorated metal-organic frameworks for enhanced photodynamic therapy","volume":"12","author":"Zhang","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioactmat.2024.05.042_bib252","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.colsurfb.2018.10.008","article-title":"A new drug carrier with oxygen generation function for modulating tumor hypoxia microenvironment in cancer chemotherapy","volume":"173","author":"Zhang","year":"2019","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"22","key":"10.1016\/j.bioactmat.2024.05.042_bib253","doi-asserted-by":"crossref","first-page":"5773","DOI":"10.1039\/C9SC00747D","article-title":"Catalase-like metal-organic framework nanoparticles to enhance radiotherapy in hypoxic cancer and prevent cancer recurrence","volume":"10","author":"Chen","year":"2019","journal-title":"Chem. Sci."},{"issue":"15","key":"10.1016\/j.bioactmat.2024.05.042_bib254","doi-asserted-by":"crossref","first-page":"1900848","DOI":"10.1002\/advs.201900848","article-title":"Monodispersed copper(I)-based nano metal-organic framework as a biodegradable drug carrier with enhanced photodynamic therapy efficacy","volume":"6","author":"Cai","year":"2019","journal-title":"Adv. Sci."},{"issue":"6","key":"10.1016\/j.bioactmat.2024.05.042_bib255","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1021\/acs.nanolett.9b01595","article-title":"Intelligent hollow Pt-CuS janus architecture for synergistic catalysis-enhanced sonodynamic and photothermal cancer therapy","volume":"19","author":"Liang","year":"2019","journal-title":"Nano Lett."},{"issue":"6","key":"10.1016\/j.bioactmat.2024.05.042_bib256","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1039\/C9NR08930F","article-title":"Biomineralization-inspired nanozyme for single-wavelength laser activated photothermal-photodynamic synergistic treatment against hypoxic tumors","volume":"12","author":"Xu","year":"2020","journal-title":"Nanoscale"},{"issue":"1","key":"10.1016\/j.bioactmat.2024.05.042_bib257","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1038\/s41467-018-04318-1","article-title":"Oxygen and Pt(II) self-generating conjugate for synergistic photo-chemo therapy of hypoxic tumor","volume":"9","author":"Xu","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioactmat.2024.05.042_bib258","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.biomaterials.2018.07.049","article-title":"Iridium nanocrystals encapsulated liposomes as near-infrared light controllable nanozymes for enhanced cancer radiotherapy","volume":"181","author":"Feng","year":"2018","journal-title":"Biomaterials"},{"issue":"12","key":"10.1016\/j.bioactmat.2024.05.042_bib259","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.7150\/thno.33141","article-title":"An in situ microenvironmental nano-regulator to inhibit the proliferation and metastasis of 4T1 tumor","volume":"9","author":"Zhang","year":"2019","journal-title":"Theranostics"},{"issue":"7","key":"10.1016\/j.bioactmat.2024.05.042_bib260","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1039\/C9BM01837A","article-title":"A robust hybrid nanozyme@hydrogel platform as a biomimetic cascade bioreactor for combination antitumor therapy","volume":"8","author":"Hao","year":"2020","journal-title":"Biomater. Sci."},{"issue":"7","key":"10.1016\/j.bioactmat.2024.05.042_bib261","doi-asserted-by":"crossref","first-page":"4323","DOI":"10.1021\/acs.nanolett.7b01382","article-title":"Enhanced phototherapy by nanoparticle-enzyme via generation and photolysis of hydrogen peroxide","volume":"17","author":"Chang","year":"2017","journal-title":"Nano Lett."},{"issue":"17","key":"10.1016\/j.bioactmat.2024.05.042_bib262","doi-asserted-by":"crossref","first-page":"6454","DOI":"10.1039\/C7CS00891K","article-title":"Catalytic chemistry of glucose oxidase in cancer diagnosis and treatment","volume":"47","author":"Fu","year":"2018","journal-title":"Chem. Soc. Rev."},{"issue":"28","key":"10.1016\/j.bioactmat.2024.05.042_bib263","doi-asserted-by":"crossref","first-page":"23528","DOI":"10.1021\/acsami.7b06814","article-title":"Glucose oxidase-polymer nanogels for synergistic cancer-starving and oxidation therapy","volume":"9","author":"Zhao","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"3","key":"10.1016\/j.bioactmat.2024.05.042_bib264","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1021\/acsnano.8b00309","article-title":"Engineering of a nanosized biocatalyst for combined tumor starvation and low-temperature photothermal therapy","volume":"12","author":"Zhou","year":"2018","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.bioactmat.2024.05.042_bib265","doi-asserted-by":"crossref","first-page":"5044","DOI":"10.1038\/s41467-018-07197-8","article-title":"A biomimetic nanoreactor for synergistic chemiexcited photodynamic therapy and starvation therapy against tumor metastasis","volume":"9","author":"Yu","year":"2018","journal-title":"Nat. Commun."},{"issue":"17","key":"10.1016\/j.bioactmat.2024.05.042_bib266","doi-asserted-by":"crossref","first-page":"15030","DOI":"10.1021\/acsami.8b01818","article-title":"MnO2 motor: A prospective cancer-starving therapy promoter","volume":"10","author":"Zhang","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"5","key":"10.1016\/j.bioactmat.2024.05.042_bib267","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1021\/acsnano.3c10129","article-title":"Biomimetic nanomedicine targeting orchestrated metabolism coupled with regulatory factors to disrupt the metabolic plasticity of breast cancer","volume":"18","author":"Meng","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioactmat.2024.05.042_bib268","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2020.111127","article-title":"Multi-functionalized nano-conjugate for combating multidrug resistant breast cancer via starvation-assisted chemotherapy","volume":"116","author":"Zhang","year":"2020","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"issue":"7","key":"10.1016\/j.bioactmat.2024.05.042_bib269","doi-asserted-by":"crossref","first-page":"7006","DOI":"10.1021\/acsnano.7b02533","article-title":"Cancer cell membrane camouflaged cascade bioreactor for cancer targeted starvation and photodynamic therapy","volume":"11","author":"Li","year":"2017","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.bioactmat.2024.05.042_bib270","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/s41467-017-00424-8","article-title":"Tumor-selective catalytic nanomedicine by nanocatalyst delivery","volume":"8","author":"Huo","year":"2017","journal-title":"Nat. Commun."},{"issue":"45","key":"10.1016\/j.bioactmat.2024.05.042_bib271","doi-asserted-by":"crossref","first-page":"14025","DOI":"10.1002\/anie.201706964","article-title":"Therapeutic vesicular nanoreactors with tumor-specific activation and self-destruction for synergistic tumor ablation","volume":"56","author":"Li","year":"2017","journal-title":"Angew. Chem. Int. Ed."},{"issue":"5","key":"10.1016\/j.bioactmat.2024.05.042_bib272","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1002\/anie.201610682","article-title":"Glucose-responsive sequential generation of hydrogen peroxide and nitric oxide for synergistic cancer starving-like\/gas therapy","volume":"56","author":"Fan","year":"2017","journal-title":"Angew. Chem. Int. Ed."},{"issue":"6","key":"10.1016\/j.bioactmat.2024.05.042_bib273","doi-asserted-by":"crossref","first-page":"5558","DOI":"10.1021\/acsnano.7b00905","article-title":"Surface-enhanced Raman scattering active gold nanoparticles with enzyme-mimicking activities for measuring glucose and lactate in living tissues","volume":"11","author":"Hu","year":"2017","journal-title":"ACS Nano"},{"issue":"3","key":"10.1016\/j.bioactmat.2024.05.042_bib274","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1021\/acsnano.8b03788","article-title":"Cancer cell membrane camouflaged nanoparticles to realize starvation therapy together with checkpoint blockade for enhancing cancer therapy","volume":"13","author":"Xie","year":"2019","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.bioactmat.2024.05.042_bib275","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1038\/s41467-018-03903-8","article-title":"In vivo guiding nitrogen-doped carbon nanozyme for tumor catalytic therapy","volume":"9","author":"Fan","year":"2018","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bioactmat.2024.05.042_bib276","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1021\/acsnano.7b07496","article-title":"Charge-switchable nanozymes for bioorthogonal imaging of biofilm-associated infections","volume":"12","author":"Gupta","year":"2018","journal-title":"ACS Nano"},{"issue":"6","key":"10.1016\/j.bioactmat.2024.05.042_bib277","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1021\/acs.nanolett.8b01522","article-title":"Catalyzed and electrocatalyzed oxidation of L-tyrosine and L-phenylalanine to dopachrome by nanozymes","volume":"18","author":"Hou","year":"2018","journal-title":"Nano Lett."},{"issue":"23","key":"10.1016\/j.bioactmat.2024.05.042_bib278","doi-asserted-by":"crossref","first-page":"6646","DOI":"10.1002\/anie.201600868","article-title":"Self-assembly of multi-nanozymes to mimic an intracellular antioxidant defense system","volume":"55","author":"Huang","year":"2016","journal-title":"Angew. Chem. Int. Ed."},{"issue":"1","key":"10.1016\/j.bioactmat.2024.05.042_bib279","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/anie.201812668","article-title":"Identification and directed development of non-organic catalysts with apparent pan-enzymatic mimicry into nanozymes for rfficient prodrug conversion","volume":"58","author":"Walther","year":"2019","journal-title":"Angew. Chem. Int. Ed."},{"issue":"1","key":"10.1016\/j.bioactmat.2024.05.042_bib280","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1038\/s41467-018-05798-x","article-title":"Biomimetic nanoflowers by self-assembly of nanozymes to induce intracellular oxidative damage against hypoxic tumors","volume":"9","author":"Wang","year":"2018","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.bioactmat.2024.05.042_bib281","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.1021\/acs.nanolett.9b00934","article-title":"Biomimetic hybrid nanozymes with self-supplied H+ and accelerated O2 generation for enhanced starvation and photodynamic therapy against hypoxic tumors","volume":"19","author":"Yang","year":"2019","journal-title":"Nano Lett."},{"key":"10.1016\/j.bioactmat.2024.05.042_bib282","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2021.145666","article-title":"Nano-realgar suppresses lung cancer stem cell growth by repressing metabolic reprogramming","volume":"788","author":"Yang","year":"2021","journal-title":"Gene"},{"issue":"10","key":"10.1016\/j.bioactmat.2024.05.042_bib283","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/nrc.2016.71","article-title":"From Krebs to clinic: Glutamine metabolism to cancer therapy","volume":"16","author":"Altman","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"6","key":"10.1016\/j.bioactmat.2024.05.042_bib284","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1172\/JCI75836","article-title":"Targeted inhibition of tumor-specific glutaminase diminishes cell\u2013autonomous tumorigenesis","volume":"125","author":"Xiang","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.bioactmat.2024.05.042_bib285","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ccr.2010.08.009","article-title":"Targeting mitochondrial glutaminase activity inhibits oncogenic transformation","volume":"18","author":"Wang","year":"2010","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.bioactmat.2024.05.042_bib286","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1158\/1535-7163.MCT-13-0870","article-title":"Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer","volume":"13","author":"Gross","year":"2014","journal-title":"Mol. Cancer Therapeut."},{"issue":"36","key":"10.1016\/j.bioactmat.2024.05.042_bib287","doi-asserted-by":"crossref","first-page":"E5328","DOI":"10.1073\/pnas.1611406113","article-title":"Combination therapy with BPTES nanoparticles and metformin targets the metabolic heterogeneity of pancreatic cancer","volume":"113","author":"Elgogary","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.bioactmat.2024.05.042_bib288","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.chembiol.2014.08.007","article-title":"Action at a distance: Allostery and the development of drugs to target cancer cell metabolism","volume":"21","author":"DeLaBarre","year":"2014","journal-title":"Chem. Biol."},{"issue":"4","key":"10.1016\/j.bioactmat.2024.05.042_bib289","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/cr.2015.33","article-title":"cMyc-mediated activation of serine biosynthesis pathway is critical for cancer progression under nutrient deprivation conditions","volume":"25","author":"Sun","year":"2015","journal-title":"Cell Res."},{"issue":"6084","key":"10.1016\/j.bioactmat.2024.05.042_bib290","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1126\/science.1218595","article-title":"Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation","volume":"336","author":"Jain","year":"2012","journal-title":"Science"},{"issue":"4\u20135","key":"10.1016\/j.bioactmat.2024.05.042_bib291","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.clinbiochem.2008.11.018","article-title":"L-arginine as a factor increasing arginase significance in diagnosis of primary and metastatic colorectal cancer","volume":"42","author":"Grabon","year":"2009","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.bioactmat.2024.05.042_bib292","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cytogfr.2017.05.004","article-title":"Amino-acid sensing and degrading pathways in immune regulation","volume":"35","author":"Grohmann","year":"2017","journal-title":"Cytokine Growth Factor Rev."},{"issue":"2","key":"10.1016\/j.bioactmat.2024.05.042_bib293","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1080\/15384047.2016.1276136","article-title":"Combination therapy with L-arginine and \u03b1-PD-L1 antibody boosts immune response against osteosarcoma in immunocompetent mice","volume":"18","author":"He","year":"2017","journal-title":"Cancer Biol. Ther."},{"issue":"3","key":"10.1016\/j.bioactmat.2024.05.042_bib294","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.cell.2016.09.031","article-title":"L-arginine modulates T cell metabolism and enhances survival and anti-tumor activity","volume":"167","author":"Geiger","year":"2016","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.bioactmat.2024.05.042_bib295","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1046\/j.1440-1711.2003.t01-1-01177.x","article-title":"Tryptophan and the immune response","volume":"81","author":"Moffett","year":"2003","journal-title":"Immunol. Cell Biol."},{"issue":"3","key":"10.1016\/j.bioactmat.2024.05.042_bib296","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3390\/vaccines3030703","article-title":"The role of indoleamine 2,3-dioxygenase in immune suppression and autoimmunity","volume":"3","author":"Mbongue","year":"2015","journal-title":"Vaccines"},{"issue":"5","key":"10.1016\/j.bioactmat.2024.05.042_bib297","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.immuni.2005.03.013","article-title":"GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase","volume":"22","author":"Munn","year":"2005","journal-title":"Immunity"},{"issue":"14","key":"10.1016\/j.bioactmat.2024.05.042_bib298","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.4161\/cbt.8.14.8882","article-title":"IDO inhibits T-cell function through suppressing Vav1 expression and activation","volume":"8","author":"Li","year":"2009","journal-title":"Cancer Biol. Ther."},{"issue":"7732","key":"10.1016\/j.bioactmat.2024.05.042_bib299","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/s41586-018-0701-2","article-title":"The metabolite BH4 controls T cell proliferation in autoimmunity and cancer","volume":"563","author":"Cronin","year":"2018","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.bioactmat.2024.05.042_bib300","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/PPO.0b013e3181eb3343","article-title":"Indoleamine 2,3-dioxygenase: Is it an immune suppressor?","volume":"16","author":"Soliman","year":"2010","journal-title":"Cancer J."},{"issue":"5","key":"10.1016\/j.bioactmat.2024.05.042_bib301","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1021\/acsmedchemlett.6b00391","article-title":"INCB24360 (Epacadostat), a highly potent and selective indoleamine-2,3-dioxygenase 1 (IDO1) inhibitor for immuno-oncology","volume":"8","author":"Yue","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"issue":"5","key":"10.1016\/j.bioactmat.2024.05.042_bib302","first-page":"307","article-title":"IDO takes a blow","volume":"17","author":"Mullard","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"34","key":"10.1016\/j.bioactmat.2024.05.042_bib303","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202102188","article-title":"Plasmon-driven catalytic chemotherapy augments cancer immunotherapy through induction of immunogenic cell death and blockage of IDO pathway","volume":"33","author":"Ding","year":"2021","journal-title":"Adv. Mater."},{"issue":"9","key":"10.1016\/j.bioactmat.2024.05.042_bib304","doi-asserted-by":"crossref","DOI":"10.1021\/acsnano.6b04989","article-title":"Synergistic transcutaneous immunotherapy enhances antitumor immune responses through delivery of checkpoint inhibitors","volume":"10","author":"Ye","year":"2016","journal-title":"ACS Nano"},{"issue":"4","key":"10.1016\/j.bioactmat.2024.05.042_bib305","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1021\/acs.nanolett.5b05030","article-title":"Enhanced cancer immunotherapy by microneedle patch-assisted delivery of anti-PD1 antibody","volume":"16","author":"Wang","year":"2016","journal-title":"Nano Lett."},{"issue":"7","key":"10.1016\/j.bioactmat.2024.05.042_bib306","doi-asserted-by":"crossref","first-page":"6644","DOI":"10.1021\/acsnano.5b03569","article-title":"Accelerating the translation of nanomaterials in biomedicine","volume":"9","author":"Mitragotri","year":"2015","journal-title":"ACS Nano"},{"issue":"12","key":"10.1016\/j.bioactmat.2024.05.042_bib307","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1038\/nbt.2759","article-title":"Vaccine delivery with microneedle skin patches in nonhuman primates","volume":"31","author":"DeMuth","year":"2013","journal-title":"Nat. Biotechnol."},{"issue":"2","key":"10.1016\/j.bioactmat.2024.05.042_bib308","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.coi.2012.12.008","article-title":"Materials based tumor immunotherapy vaccines","volume":"25","author":"Li","year":"2013","journal-title":"Curr. Opin. Immunol."},{"issue":"2","key":"10.1016\/j.bioactmat.2024.05.042_bib309","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2012.06.011","article-title":"Cancer cachexia: Mediators, signaling, and metabolic pathways","volume":"16","author":"Fearon","year":"2012","journal-title":"Cell Metabol."},{"issue":"2","key":"10.1016\/j.bioactmat.2024.05.042_bib310","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2013.05.017","article-title":"Cellular fatty acid metabolism and cancer","volume":"18","author":"Currie","year":"2013","journal-title":"Cell Metabol."},{"issue":"7","key":"10.1016\/j.bioactmat.2024.05.042_bib311","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.cell.2015.05.025","article-title":"ER stress sensor XBP1 controls anti-tumor immunity by disrupting dendritic cell homeostasis","volume":"161","author":"Cubillos-Ruiz","year":"2015","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.bioactmat.2024.05.042_bib312","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1344804","article-title":"Exogenous lipid uptake induces metabolic and functional reprogramming of tumor-associated myeloid-derived suppressor cells","volume":"6","author":"Al-Khami","year":"2017","journal-title":"OncoImmunology"},{"issue":"1","key":"10.1016\/j.bioactmat.2024.05.042_bib313","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/s41467-017-00523-6","article-title":"Caspase-1 cleaves PPAR\u03b3 for potentiating the pro-tumor action of TAMs","volume":"8","author":"Niu","year":"2017","journal-title":"Nat. Commun."},{"issue":"7596","key":"10.1016\/j.bioactmat.2024.05.042_bib314","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nature17412","article-title":"Potentiating the antitumour response of CD8+ T cells by modulating cholesterol metabolism","volume":"531","author":"Yang","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.bioactmat.2024.05.042_bib315","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2022.101618","article-title":"Reprogramming dysfunctional dendritic cells by a versatile metabolism nano-intervenor for enhancing cancer combinatorial immunotherapy","volume":"46","author":"Yang","year":"2022","journal-title":"Nano Today"},{"key":"10.1016\/j.bioactmat.2024.05.042_bib316","doi-asserted-by":"crossref","first-page":"e189","DOI":"10.1038\/oncsis.2015.49","article-title":"Lipid metabolic reprogramming in cancer cells","volume":"5","author":"Beloribi-Djefaflia","year":"2016","journal-title":"Oncogenesis"},{"issue":"9","key":"10.1016\/j.bioactmat.2024.05.042_bib317","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.bbamcr.2014.04.012","article-title":"Molecular monitoring of epithelial-to-mesenchymal transition in breast cancer cells by means of Raman spectroscopy","volume":"1843","author":"Marro","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.bioactmat.2024.05.042_bib318","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1091\/mbc.e08-09-0898","article-title":"Specific activation of mitogen-activated protein kinase by transforming growth factor-\u03b2 receptors in lipid rafts is required for epithelial cell plasticity","volume":"20","author":"Zuo","year":"2009","journal-title":"Mol. Biol. Cell"},{"issue":"1","key":"10.1016\/j.bioactmat.2024.05.042_bib319","doi-asserted-by":"crossref","first-page":"265","DOI":"10.7150\/thno.27246","article-title":"Targeting lipid metabolism to overcome EMT-associated drug resistance via integrin \u03b23\/FAK pathway and tumor-associated macrophage repolarization using legumain-activatable delivery","volume":"9","author":"Jin","year":"2019","journal-title":"Theranostics"},{"issue":"9","key":"10.1016\/j.bioactmat.2024.05.042_bib320","doi-asserted-by":"crossref","first-page":"10301","DOI":"10.1021\/acsnano.9b03727","article-title":"Biomimetic magnetic nanostructures: A theranostic platform targeting lipid metabolism and immune response in lymphoma","volume":"13","author":"Singh","year":"2019","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.bioactmat.2024.05.042_bib321","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ccell.2018.12.002","article-title":"Gain fat-lose metastasis: Converting invasive breast cancer cells into adipocytes ainhibits cancer metastasis","volume":"35","author":"Ishay-Ronen","year":"2019","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.bioactmat.2024.05.042_bib322","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1023\/A:1006416410198","article-title":"5-Fluorouracil: Forty-plus and still ticking. A review of its preclinical and clinical development","volume":"18","author":"Grem","year":"2000","journal-title":"Invest. New Drugs"},{"issue":"37","key":"10.1016\/j.bioactmat.2024.05.042_bib323","doi-asserted-by":"crossref","first-page":"32552","DOI":"10.1074\/jbc.M111.236117","article-title":"Nucleobase transport by human equilibrative nucleoside transporter 1 (hENT1)","volume":"286","author":"Yao","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.bioactmat.2024.05.042_bib324","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrc1074","article-title":"5-fluorouracil: Mechanisms of action and clinical strategies","volume":"3","author":"Longley","year":"2003","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.bioactmat.2024.05.042_bib325","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/0006-291X(74)90601-9","article-title":"Purification and amino acid analysis of an active site peptide from thymidylate synthetase containing covalently bound 5-fluoro-2'-deoxyuridylate and methylenetetrahydrofolate","volume":"57","author":"Sommer","year":"1974","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"8","key":"10.1016\/j.bioactmat.2024.05.042_bib326","doi-asserted-by":"crossref","first-page":"4966","DOI":"10.1073\/pnas.77.8.4966","article-title":"Improving the anti-tumor activity of 5-fluorouracil by increasing its incorporation into RNA via metabolic modulation","volume":"77","author":"Spiegelman","year":"1980","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bioactmat.2024.05.042_bib327","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.biomaterials.2015.11.033","article-title":"Combined sonodynamic and antimetabolite therapy for the improved treatment of pancreatic cancer using oxygen loaded microbubbles as a delivery vehicle","volume":"80","author":"McEwan","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioactmat.2024.05.042_bib328","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jconrel.2017.07.040","article-title":"Magnetically responsive microbubbles as delivery vehicles for targeted sonodynamic and antimetabolite therapy of pancreatic cancer","volume":"262","author":"Sheng","year":"2017","journal-title":"J. Control. Release"},{"issue":"29","key":"10.1016\/j.bioactmat.2024.05.042_bib329","doi-asserted-by":"crossref","first-page":"8994","DOI":"10.1002\/anie.201804156","article-title":"Floxuridine homomeric oligonucleotides \u201cHitchhike\u201d with albumin in situ for cancer chemotherapy","volume":"57","author":"Jin","year":"2018","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioactmat.2024.05.042_bib330","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.119848","article-title":"Iridium\/ruthenium nanozyme reactors with cascade catalytic ability for synergistic oxidation therapy and starvation therapy in the treatment of breast cancer","volume":"238","author":"Wei","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioactmat.2024.05.042_bib331","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.119765","article-title":"Homotypic targeting upconversion nano-reactor for cascade cancer starvation and deep-tissue phototherapy","volume":"235","author":"Wang","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioactmat.2024.05.042_bib332","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.119771","article-title":"Light-activated oxygen self-supplied starving therapy in near-infrared (NIR) window and adjuvant hyperthermia-induced tumor ablation with an augmented sensitivity","volume":"234","author":"Ren","year":"2020","journal-title":"Biomaterials"},{"issue":"12","key":"10.1016\/j.bioactmat.2024.05.042_bib333","doi-asserted-by":"crossref","first-page":"13985","DOI":"10.1021\/acsnano.9b05836","article-title":"Biodegradable manganese-doped calcium phosphate nanotheranostics for traceable cascade reaction-enhanced anti-tumor therapy","volume":"13","author":"Fu","year":"2019","journal-title":"ACS Nano"},{"issue":"8","key":"10.1016\/j.bioactmat.2024.05.042_bib334","doi-asserted-by":"crossref","first-page":"8903","DOI":"10.1021\/acsnano.9b02477","article-title":"Organosilica-based hollow mesoporous bilirubin nanoparticles for antioxidation-activated self-protection and tumor-specific deoxygenation-driven synergistic therapy","volume":"13","author":"Shan","year":"2019","journal-title":"ACS Nano"},{"issue":"8","key":"10.1016\/j.bioactmat.2024.05.042_bib335","doi-asserted-by":"crossref","first-page":"5674","DOI":"10.1021\/acs.nanolett.9b02253","article-title":"Nanozymes-engineered metal-organic frameworks for catalytic cascades-enhanced synergistic cancer therapy","volume":"19","author":"Liu","year":"2019","journal-title":"Nano Lett."},{"issue":"3","key":"10.1016\/j.bioactmat.2024.05.042_bib336","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1021\/acsnano.8b03788","article-title":"Cancer cell membrane camouflaged nanoparticles to realize starvation therapy together with checkpoint blockades for enhancing cancer therapy","volume":"13","author":"Xie","year":"2019","journal-title":"ACS Nano"},{"issue":"10","key":"10.1016\/j.bioactmat.2024.05.042_bib340","doi-asserted-by":"crossref","first-page":"10201","DOI":"10.1021\/acsnano.8b05200","article-title":"Erythrocyte membrane cloaked metal-organic framework nanoparticle as biomimetic nanoreactor for starvation-activated colon cancer therapy","volume":"12","author":"Zhang","year":"2018","journal-title":"ACS Nano"},{"issue":"44","key":"10.1016\/j.bioactmat.2024.05.042_bib342","doi-asserted-by":"crossref","first-page":"5402","DOI":"10.1039\/D0CC07544B","article-title":"An enzyme nanopocket based on covalent organic frameworks for long-term starvation therapy and enhanced photodynamic therapy of cancer","volume":"57","author":"Wan","year":"2021","journal-title":"Chem. Commun."},{"issue":"11","key":"10.1016\/j.bioactmat.2024.05.042_bib382","doi-asserted-by":"crossref","first-page":"11000","DOI":"10.1021\/acsnano.8b05042","article-title":"Magnetic targeting, tumor microenvironment-responsive intelligent nanocatalysts for enhanced tumor ablation","volume":"12","author":"Feng","year":"2018","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.bioactmat.2024.05.042_bib362","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1038\/s41467-017-01651-9","article-title":"Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression","volume":"8","author":"Lu","year":"2017","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.bioactmat.2024.05.042_bib363","doi-asserted-by":"crossref","first-page":"6647","DOI":"10.1021\/acs.nanolett.9b02923","article-title":"A three-in-one immunotherapy nanoweapon via cascade-amplifying cancer-immunity cycle against tumor metastasis, relapse, and postsurgical regrowth","volume":"19","author":"Li","year":"2019","journal-title":"Nano Lett."},{"issue":"5","key":"10.1016\/j.bioactmat.2024.05.042_bib364","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1021\/acs.nanolett.8b01071","article-title":"Sequentially responsive therapeutic peptide assembling nanoparticles for dual-targeted cancer immunotherapy","volume":"18","author":"Cheng","year":"2018","journal-title":"Nano Lett."},{"issue":"8","key":"10.1016\/j.bioactmat.2024.05.042_bib365","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1021\/acs.nanolett.9b01807","article-title":"Nanoenabled reversal of IDO1-mediated immunosuppression synergizes with immunogenic chemotherapy for improved cancer therapy","volume":"19","author":"Huang","year":"2019","journal-title":"Nano Lett."},{"issue":"1","key":"10.1016\/j.bioactmat.2024.05.042_bib366","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1021\/acs.nanolett.9b04012","article-title":"Sheddable prodrug vesicles combating adaptive immune resistance for improved photodynamic immunotherapy of cancer","volume":"20","author":"Gao","year":"2020","journal-title":"Nano Lett."},{"issue":"10","key":"10.1016\/j.bioactmat.2024.05.042_bib367","doi-asserted-by":"crossref","first-page":"6964","DOI":"10.1021\/acs.nanolett.9b02306","article-title":"Redox-activated porphyrin-based liposome remote-loaded with indoleamine 2,3-dioxygenase (IDO) inhibitor for synergistic photoimmunotherapy through induction of immunogenic cell death and blockage of Ido pathway","volume":"19","author":"Liu","year":"2019","journal-title":"Nano Lett."},{"key":"10.1016\/j.bioactmat.2024.05.042_bib368","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.actbio.2019.03.048","article-title":"Dual functional immunostimulatory polymeric prodrug carrier with pendent indoximod for enhanced cancer immunochemotherapy","volume":"90","author":"Wan","year":"2019","journal-title":"Acta Biomater."},{"issue":"8","key":"10.1016\/j.bioactmat.2024.05.042_bib369","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1002\/ijc.31588","article-title":"A new cancer immunotherapy via simultaneous DC-mobilization and DC-targeted IDO gene silencing using an immune-stimulatory nanosystem","volume":"143","author":"Zhang","year":"2018","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.bioactmat.2024.05.042_bib370","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1021\/acs.molpharmaceut.5b00447","article-title":"Development of a self-assembled nanoparticle formulation of orlistat, nano-ORL, with increased cytotoxicity against human tumor cell lines","volume":"13","author":"Hill","year":"2016","journal-title":"Mol. Pharm."},{"issue":"6","key":"10.1016\/j.bioactmat.2024.05.042_bib371","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.biopha.2014.07.016","article-title":"Anti-tumorigenic effect of nano formulated peptide pACC1 by diminishing de novo lipogenisis in DMBA induced mammary carcinoma rat model","volume":"68","author":"Kaliaperumal","year":"2014","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.bioactmat.2024.05.042_bib372","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1002\/jcp.29358","article-title":"Combined effects of avasimibe immunotherapy, doxorubicin chemotherapy, and metal-organic frameworks nanoparticles on breast cancer","volume":"235","author":"Lei","year":"2020","journal-title":"J. Cell. Physiol."},{"issue":"3","key":"10.1016\/j.bioactmat.2024.05.042_bib373","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1021\/acs.nanolett.6b03329","article-title":"Lipid nanoparticle assisted mRNA delivery for potent cancer immunotherapy","volume":"17","author":"Oberli","year":"2017","journal-title":"Nano Lett."},{"issue":"1","key":"10.1016\/j.bioactmat.2024.05.042_bib374","doi-asserted-by":"crossref","first-page":"21","DOI":"10.29252\/ibj.23.1.21","article-title":"Anti-mucin1 aptamer-conjugated chitosan nanoparticles for targeted co-delivery of docetaxel and IGF-1R siRNA to SKBR3 metastatic breast cancer cells","volume":"23","author":"Jafari","year":"2019","journal-title":"Iran. Biomed. J."},{"issue":"29","key":"10.1016\/j.bioactmat.2024.05.042_bib375","doi-asserted-by":"crossref","first-page":"7117","DOI":"10.1016\/j.biomaterials.2013.05.043","article-title":"Selective metabolic effects of gold nanorods on normal and cancer cells and their application in anticancer drug screening","volume":"34","author":"Zhang","year":"2013","journal-title":"Biomaterials"},{"issue":"42","key":"10.1016\/j.bioactmat.2024.05.042_bib376","doi-asserted-by":"crossref","DOI":"10.1088\/0957-4484\/25\/42\/425102","article-title":"Layered gadolinium-based nanoparticle as a novel delivery platform for microRNA therapeutics","volume":"25","author":"Yoo","year":"2014","journal-title":"Nanotechnology"},{"issue":"10","key":"10.1016\/j.bioactmat.2024.05.042_bib377","doi-asserted-by":"crossref","first-page":"9731","DOI":"10.1021\/acsnano.5b02471","article-title":"Systemic delivery of anti-miRNA for suppression of triple negative breast cancer utilizing RNA nanotechnology","volume":"9","author":"Shu","year":"2015","journal-title":"ACS Nano"},{"issue":"3","key":"10.1016\/j.bioactmat.2024.05.042_bib379","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1021\/acsnano.5b08145","article-title":"Near infrared-guided smart nanocarriers for microRNA-controlled release of doxorubicin\/siRNA with intracellular ATP as fuel","volume":"10","author":"Zhang","year":"2016","journal-title":"ACS Nano"},{"issue":"9","key":"10.1016\/j.bioactmat.2024.05.042_bib380","doi-asserted-by":"crossref","first-page":"7681","DOI":"10.1021\/nn301135w","article-title":"Gene silencing by gold nanoshell-mediated delivery and laser-triggered release of antisense oligonucleotide and siRNA","volume":"6","author":"Huschka","year":"2012","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.bioactmat.2024.05.042_bib343","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.tibs.2013.12.004","article-title":"KRAS: Feeding pancreatic cancer proliferation, Trends","volume":"39","author":"Bryant","year":"2014","journal-title":"Biochem. Sci."},{"issue":"7","key":"10.1016\/j.bioactmat.2024.05.042_bib344","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202306203","article-title":"Nanoenabled intracellular metal ion homeostasis regulation for tumor therapy","volume":"11","author":"Xu","year":"2024","journal-title":"Adv. Sci."},{"issue":"9","key":"10.1016\/j.bioactmat.2024.05.042_bib345","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202317578","article-title":"Photo-controlled calcium overload from endogenous sources for tumor therapy","volume":"63","author":"Hu","year":"2024","journal-title":"Angew. Chem. Int. Ed."},{"issue":"3","key":"10.1016\/j.bioactmat.2024.05.042_bib346","doi-asserted-by":"crossref","first-page":"2209291","DOI":"10.1002\/adfm.202209291","article-title":"Recent advances in calcium-based anticancer nanomaterials exploiting calcium overload to trigger cell apoptosis","volume":"33","author":"Xiao","year":"2023","journal-title":"Adv. Funct. Mater."},{"issue":"4","key":"10.1016\/j.bioactmat.2024.05.042_bib347","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.cell.2021.12.039","article-title":"Magnesium sensing via LFA-1 regulates CD8+ T cell effector function","volume":"185","author":"Lotscher","year":"2022","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bioactmat.2024.05.042_bib348","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202304098","article-title":"GSH\/pH dual activatable cross-linked and fluorinated PEI for cancer gene therapy through endogenous iron de-hijacking and in situ ROS amplification","volume":"36","author":"Yang","year":"2024","journal-title":"Adv. Mater."},{"issue":"51","key":"10.1016\/j.bioactmat.2024.05.042_bib349","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202207174","article-title":"Ferritin-hijacking nanoparticles spatiotemporally directing endogenous ferroptosis for synergistic anticancer therapy","volume":"34","author":"Zhu","year":"2022","journal-title":"Adv. Mater."},{"issue":"20","key":"10.1016\/j.bioactmat.2024.05.042_bib350","doi-asserted-by":"crossref","first-page":"19581","DOI":"10.1021\/acsnano.3c07775","article-title":"Cuproptosis: Harnessing transition metal for cancer therapy","volume":"17","author":"Wang","year":"2023","journal-title":"ACS Nano"},{"issue":"12","key":"10.1016\/j.bioactmat.2024.05.042_bib351","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202213922","article-title":"Photothermally triggered copper payload release for cuproptosis-promoted cancer synergistic therapy","volume":"62","author":"Zhou","year":"2023","journal-title":"Angew. Chem. Int. Ed."},{"issue":"8","key":"10.1016\/j.bioactmat.2024.05.042_bib352","doi-asserted-by":"crossref","first-page":"11862","DOI":"10.1021\/acsnano.2c00969","article-title":"Biodegradable MnO-based nanoparticles with engineering surface for tumor therapy: Simultaneous fenton-like ion delivery and immune activation","volume":"16","author":"Sun","year":"2022","journal-title":"ACS Nano"},{"issue":"8","key":"10.1016\/j.bioactmat.2024.05.042_bib353","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202216917","article-title":"Disruption of zinc homeostasis by a novel platinum(IV)-terthiophene complex for antitumor immunity","volume":"62","author":"Su","year":"2023","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioactmat.2024.05.042_bib354","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122333","article-title":"An acid-responsive MOF nanomedicine for augmented anti-tumor immunotherapy via a metal ion interference-mediated pyroptotic pathway","volume":"302","author":"Feng","year":"2023","journal-title":"Biomaterials"},{"issue":"31","key":"10.1016\/j.bioactmat.2024.05.042_bib355","doi-asserted-by":"crossref","first-page":"16763","DOI":"10.1002\/anie.202102574","article-title":"Antitumor agents based on metal-organic frameworks","volume":"60","author":"Gao","year":"2021","journal-title":"Angew. Chem. Int. Ed."},{"issue":"1","key":"10.1016\/j.bioactmat.2024.05.042_bib356","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.1038\/s41467-023-40345-3","article-title":"A bimetallic nanoplatform for STING activation and CRISPR\/Cas mediated depletion of the methionine transporter in cancer cells restores anti-tumor immune responses","volume":"14","author":"Huang","year":"2023","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.bioactmat.2024.05.042_bib357","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/s41565-021-00962-9","article-title":"Amplifying STING activation by cyclic dinucleotide-manganese particles for local and systemic cancer metalloimmunotherapy","volume":"16","author":"Sun","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.bioactmat.2024.05.042_bib358","doi-asserted-by":"crossref","first-page":"215654","DOI":"10.1016\/j.ccr.2023.215654","article-title":"Recent advances in the metal\/organic hybrid nanomaterials for cancer theranostics","volume":"504","author":"Ye","year":"2024","journal-title":"Coord. Chem. Rev."},{"issue":"Pt A","key":"10.1016\/j.bioactmat.2024.05.042_bib359","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jconrel.2016.11.015","article-title":"To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine?","volume":"244","author":"Danhier","year":"2016","journal-title":"J. Control. Release"},{"issue":"6","key":"10.1016\/j.bioactmat.2024.05.042_bib360","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.ejca.2004.01.003","article-title":"Integrating pharmacology and in vivo cancer models in preclinical and clinical drug development","volume":"40","author":"Peterson","year":"2004","journal-title":"Eur. J. Cancer"},{"issue":"2\u20133","key":"10.1016\/j.bioactmat.2024.05.042_bib361","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1242\/dmm.000976","article-title":"Mouse xenograft models vs GEM models for human cancer therapeutics","volume":"1","author":"Richmond","year":"2008","journal-title":"Dis. Model Mech."}],"container-title":["Bioactive Materials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X24002081?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X24002081?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,11]],"date-time":"2024-08-11T00:06:26Z","timestamp":1723334786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452199X24002081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":377,"alternative-id":["S2452199X24002081"],"URL":"https:\/\/doi.org\/10.1016\/j.bioactmat.2024.05.042","relation":{},"ISSN":["2452-199X"],"issn-type":[{"value":"2452-199X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biochemical hallmarks-targeting antineoplastic nanotherapeutics","name":"articletitle","label":"Article Title"},{"value":"Bioactive Materials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioactmat.2024.05.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}